<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Arch Paediatr Dent</journal-id><journal-id journal-id-type="iso-abbrev">Eur Arch Paediatr Dent</journal-id><journal-title-group><journal-title>European Archives of Paediatric Dentistry</journal-title></journal-title-group><issn pub-type="ppub">1818-6300</issn><issn pub-type="epub">1996-9805</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39821495</article-id><article-id pub-id-type="pmc">PMC11972179</article-id>
<article-id pub-id-type="publisher-id">988</article-id><article-id pub-id-type="doi">10.1007/s40368-024-00988-2</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Scientific Article</subject></subj-group></article-categories><title-group><article-title>Efficiency of glass ionomer sealant application in reducing hypersensitivity in MIH-molars in schoolchildren immediately and after 12 weeks</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Karim</surname><given-names>R.</given-names></name><address><email>ramiar.karim@stud.uni-greifswald.de</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Baider</surname><given-names>M.</given-names></name><address><email>mohamed.baider@uni-greifswald.de</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Splieth</surname><given-names>C. H.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Schmoeckel</surname><given-names>J.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/025vngs54</institution-id><institution-id institution-id-type="GRID">grid.412469.c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9116 8976</institution-id><institution>Department of Paediatric Dentistry, </institution><institution>University Medicine Greifswald, </institution></institution-wrap>Walther-Rathenau-Stra&#x000df;e 42a, Greifswald, Germany </aff></contrib-group><pub-date pub-type="epub"><day>17</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>17</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>26</volume><issue>2</issue><fpage>361</fpage><lpage>373</lpage><history><date date-type="received"><day>14</day><month>8</month><year>2024</year></date><date date-type="accepted"><day>2</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Aim</title><p id="Par1">This prospective clinical study aimed to clinically investigate&#x000a0;the efficiency of (GIC) glass-ionomer cement application (Ionostar Plus&#x02009;+&#x02009;Easy Glaze, VOCO) in reducing hypersensitivity in permanent molars affected by molar incisor hypomineralisation when assessed immediately (15 min) and 12 weeks after its application.</p></sec><sec><title>Materials and Methods</title><p id="Par2">Children with at least one hypersensitive MIH-affected permanent molar (MIH-TNI-3 or 4). The pre-treatment status was evaluated and only included if they did not receive a tooth-specific in-office desensitizing treatment within one month. Clinical pain assessments were performed using the schiff score air sensitivity scale (SCASS) and Wong-baker faces Scale (WBFS).</p></sec><sec><title>Results</title><p id="Par3">This study involved 25 participants (mean age 8.6&#x02009;&#x000b1;&#x02009;1.85 years) with 43 hypersensitive MIH-molars of which about half were SCASS 3 (<italic>n</italic>&#x02009;=&#x02009;24, 55.8%) and SCASS 2 (<italic>n</italic>&#x02009;=&#x02009;19, 44.2%). Regarding hypersensitivity, the reported mean SCASS score reduced significantly from 2.56 (&#x000b1;&#x02009;0.50) at baseline to 1.14 (&#x000b1;&#x02009;0.96) after 15 min of GIC sealant application and even further to 0.71 (&#x000b1;&#x02009;0.89) after 12 weeks (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001, Paired&#x000a0;<italic>t</italic>&#x000a0;test). Similarly, reported WBFS scores also significantly reduced from 5.81 (&#x000b1;&#x02009;2.50; Range&#x02009;=&#x02009;2&#x02013;10) at baseline to 2.88 (&#x000b1;&#x02009;2.31; Range&#x02009;=&#x02009;0&#x02013;10) after 15 min and to 2.95 (&#x000b1;&#x02009;2.17) after 12 weeks, respectively (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001, Paired&#x000a0;<italic>t</italic>&#x000a0;test). The mean reduction in SCASS scores was 1.3 (&#x000b1;&#x02009;0.6) and 1.4 (&#x000b1;&#x02009;1.0) for baseline SCASS 2 vs. 3, respectively.</p></sec><sec><title>Conclusion</title><p id="Par4">GIC coverage is effective in providing clear instant relief from hypersensitivity in MIH molars in schoolchildren, which improves even further over a period of 12 weeks.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1007/s40368-024-00988-2.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Hypersensitivity</kwd><kwd>Molar incisor hypomineralisation</kwd><kwd>Glass-ionomer cement</kwd><kwd>Schiff score air sensitivity scale</kwd><kwd>Wong-baker faces Scale</kwd></kwd-group><funding-group><award-group><funding-source><institution>VOCO</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100020027</institution-id><institution>Dr. Rolf M. Schwiete Stiftung</institution></institution-wrap></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Universit&#x000e4;tsmedizin Greifswald (8976)</institution></funding-source></award-group><open-access><p>Open Access funding enabled and organized by Projekt DEAL.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; European Academy of Paediatric Dentistry 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">Molar incisor hypomineralisation (MIH) is a qualitative developmental defect of unknown origin with a worldwide prevalence of 14.2% that affects one or more first permanent molars with or without incisors involvement (Zhao et al. <xref ref-type="bibr" rid="CR42">2018</xref>). Clinical features of MIH involve a demarcated opacity with chromatic changes that vary from white/cream to yellow/brownish, which can be seen as an alteration in enamel translucency (Weerheijm <xref ref-type="bibr" rid="CR40">2003</xref>). In addition, the condition is associated with clinical complications such as enamel loss, increased risk of caries development, post-eruptive breakdown due to masticatory efforts and mostly severe hypersensitivity resulting in pain and discomfort (Lygidakis <xref ref-type="bibr" rid="CR28">2010</xref>).</p><p id="Par6">Hypersensitivity is considered as one major symptom in children with MIH with a prevalence of 23% (Raposo et al. <xref ref-type="bibr" rid="CR33">2019</xref>). The reason for this hypersensitivity is still not clearly understood in detail. However, the affected enamel is characterized by an increased porosity which leads to reduced thermal isolation properties and altered thermal conductivity (Fagrell et al. <xref ref-type="bibr" rid="CR21">2010</xref>). This increased hypersensitivity leads to deterioration of oral hygiene with increased plaque accumulation resulting in increased susceptibility to caries formation (Americano et al., 2017). MIH-affected teeth are nearly 10 times more susceptible to caries development and exhibit difficulty in dental anaesthesia (Jalevik &#x00026; Klingberg, <xref ref-type="bibr" rid="CR22">2002</xref>). These clinical complications of MIH have functional, aesthetic and social effects resulting in reduced oral health-related quality of life (OHRQoL) of children (Awwad et al. <xref ref-type="bibr" rid="CR5">2023</xref>).</p><p id="Par7">The management of MIH teeth varies based on severity. A wide range of treatment options are currently available ranging from caries and enamel breakdown prevention, management of hypersensitivity, restorative treatment, and extraction with or without combined orthodontic treatment (Lygidakis et al. <xref ref-type="bibr" rid="CR30">2022</xref>; Bekes et al. <xref ref-type="bibr" rid="CR11">2023</xref>). Preventive management involves thorough oral hygiene instruction, brushing with fluoride-containing toothpaste as well as the application of other topical fluoride varnish (e.g.22.600 ppm fluoride) combined with frequent recall visits (Baroni &#x00026; Marchionni <xref ref-type="bibr" rid="CR8">2011</xref>).</p><p id="Par8">Regarding hypersensitivity several products are suggested for remineralisation and desensitisation purposes. Such as casein phosphopeptide-amorphous calcium phosphate (CPP-ACP), which showed a superior effect in the reduction of tooth hypersensitivity compared to usual fluoride toothpastes (Pasini et al., 2018). In addition, similar results were reported with arginine-containing products, which reported a significant reduction in the degree of hypersensitivity in MIH molars after a period of 3 months (Bekes et al. <xref ref-type="bibr" rid="CR12">2017</xref>). Whereas, silver diamine fluoride (SDF) is also looked at as non-invasive desensitising agent, which acts to block dentinal tubules by producing fluorohydroxyapatite and increasing mineral density and hardness resulting in relief of tooth hypersensitivity but with the draw-back of potential black discolorations (Al-Nerabieah et al., <xref ref-type="bibr" rid="CR2">2024</xref>).</p><p id="Par9">The preventive approach through sealant application is known as an acceptable, widely available and feasible for prevention or control of caries on occlusal surface, which enhance tissue remineralisation, inhibit the biofilm formation and provide a cleansable surface (Ahovuo-Saloranta et al. <xref ref-type="bibr" rid="CR1">2017</xref>). Furthermore, sealed occlusal surfaces in children showed a significant reduction in caries progression compared to unsealed occlusal surfaces (Llodra et al. <xref ref-type="bibr" rid="CR27">1993</xref>). Children affected with MIH are more frequently anxious. This may make restorative procedures challenging. Hence the use of simplified sealant application avoiding adhesively bonded sealants, which involves the use of conventional acid etching and water spray and drying making the procedure technique sensitive, and hence increasing patients discomfort in hypersensitive teeth.</p><p id="Par10">Generally spoken, current guidelines such as the &#x0201c;W&#x000fc;rzburg concept 2.0&#x0201d; suggest the application of a sealant for MIH teeth with and without breakdown as an initial therapy to reduce pain (Bekes et al. <xref ref-type="bibr" rid="CR11">2023</xref>). This is supported by the current practice guidance of European Academy of Paediatric Dentistry, in which GIC sealant is defined as an atraumatic restoration in children, who lack cooperation for invasive treatment requiring local anaesthetics (Lygidakis et al. <xref ref-type="bibr" rid="CR30">2022</xref>). Nevertheless, few clinical studies have been published regarding the immediate and mid-term effect of GIC sealant on the reduction of hypersensitivity in MIH molars with and without enamel breakdown which may not be used to influence caries risk but to reduce hypersensitivity via an easy tool. Therefore, the aim of this study is to prospectively investigate&#x000a0;the clinical efficiency of (GIC) glass-ionomer cement application (Ionostar Plus&#x02009;+&#x02009;Easy Glaze, VOCO) in reducing hypersensitivity in permanent molars affected by molar incisor hypomineralisation when assessed immediately (15 min) and 3 months after its application.</p></sec><sec id="Sec2"><title>Material and methods</title><p id="Par11">This prospective interventional clinical study was approved by the Ethics Committee (BB 047 /23) of the University medicine Greifswald, Germany and was conducted in strict adherence to the STROBE checklist (appendix <xref rid="MOESM1" ref-type="media">1</xref>). The study protocol was registered on ClinicalTrials (NCT05945381). All caregivers were asked to sign an informed consent after thorough explanation of the study procedures and outcomes of treatment. Children would have been excluded from the study when their caregivers had refused to give informed consent. As shown in the flow-chart of the study representing the outline of the study design all eligible patients gave consent (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>) but one patient was excluded as not all inclusion criteria were fulfilled.<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Flow-chart of the study design</p></caption><graphic xlink:href="40368_2024_988_Fig1_HTML" id="MO1"/></fig></p><sec id="Sec3"><title>Selection of the participants</title><p id="Par12">The participants of this study were either new patients to the paediatric dentistry department of the University Dental Hospital (Greifswald) with newly erupted hypersensitive MIH molars or recall patients with persisting hypersensitivity. These children usually had a history of desensitising treatment which was recorded based on their dental records. For the diagnosis of MIH teeth, the criteria defined by the W&#x000fc;rzburg concept based on the MIH treatment need index (MIH-TNI) was used (Steffen et al., 2017).</p><p id="Par13">The inclusion criteria of the study were as follows:<list list-type="bullet"><list-item><p id="Par14">Self-reported hypersensitive MIH molar with and/or without enamel breakdown (MIH-TNI 3 &#x00026; 4a/b/c)</p></list-item><list-item><p id="Par15">Hypersensitive MIH affected molars with a score of 2 or 3 on the Schiff cold air sensitivity score (SCASS; Schiff et al. <xref ref-type="bibr" rid="CR35">2009</xref>)</p></list-item><list-item><p id="Par16">Children &#x00026; adolescents without systematic health diseases</p></list-item><list-item><p id="Par17">No sealing therapy or application of desensitizing agent on the MIH teeth within 1&#x000a0;month before participation in the study</p></list-item><list-item><p id="Par18">Agreement to voluntary participation in the study (informed consent)</p></list-item></list></p><p id="Par19">Whereas the exclusion criteria involved:<list list-type="bullet"><list-item><p id="Par20">Patients with acute pain/ patients with signs or symptoms to be treated</p></list-item><list-item><p id="Par21">Patients with systemic disease that require special attention during their dental treatment</p></list-item><list-item><p id="Par22">Parents / children who refused to participate in the study.</p></list-item><list-item><p id="Par23">MIH teeth with signs of irreversible pulpitis</p></list-item><list-item><p id="Par24">Allergy against any ingredients of the study material</p></list-item></list></p></sec><sec id="Sec4"><title>Sample size calculation</title><p id="Par25">Sample size calculation was performed based on findings from a previous study, showing a minimum significant difference of 1 in SCASS scores (Bekes et al. <xref ref-type="bibr" rid="CR12">2017</xref>). The probability of the study detecting a treatment difference was assumed to be 80% at a two-sided 0.05 significance level and resulted in a required enrolment of at least 19 participants with at least one affected MIH molar. To reduce the risk of drop-out (of approximately 25%) for the 12 weeks&#x02019; follow-up, an increase of 25% lead to a final required baseline sample of 25 participants.</p></sec><sec id="Sec5"><title>Assessment tools</title><p id="Par26">The intra-oral examination of the potential participant for inclusion, baseline assessment, immediate effect (15 min after application) and 12 weeks&#x02019; reassessment were performed by two trained and calibrated study dentists (RK &#x00026; MB). In each case, the grade of the hypersensitivity of the MIH teeth was performed in response to the air-blast hypersensitivity test via schiff cold air sensitivity score (SCASS). The air blast was applied perpendicularly on the occlusal surface of the tooth for 1 s at a distance of 1 cm. The adjacent teeth were shielded with the finger of the examiner, the same shielding technique was used in previous studies to assess MIH hypersensitivity in schoolchildren (Bekes et al. <xref ref-type="bibr" rid="CR10">2022</xref>, <xref ref-type="bibr" rid="CR12">2017</xref>). The patient&#x02019;s response to the air blast was recorded according to the SCASS score as shown below in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> which is considered the more objective parameter (Schiff et al. <xref ref-type="bibr" rid="CR35">2009</xref>). Whereas the subjective pain intensity of the participant to the air-blast test was recorded with the Wong baker faces scale (WBFS) resembling the range &#x0201c;0&#x02009;=&#x02009;no hurt&#x0201d; to &#x0201c;10&#x02009;=&#x02009;hurts worst&#x0201d; (Wong &#x00026; Baker, 1998).<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Schiff Cold Air Sensitivity Score (SCASS; Schiff et al. <xref ref-type="bibr" rid="CR35">2009</xref><bold>)</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Grade</th><th align="left">Description</th></tr></thead><tbody><tr><td align="left">0</td><td align="left">Subject does not respond to the stimulus</td></tr><tr><td align="left">1</td><td align="left">Subject does not respond to the stimulus, but considers stimulus to be painful</td></tr><tr><td align="left">2</td><td align="left">Subject responds to air stimulus and moves from the stimulus</td></tr><tr><td align="left">3</td><td align="left">Subject responds to air stimulus, moves from the stimulus, and requests immediate discontinuation of the stimulus</td></tr></tbody></table></table-wrap></p><p id="Par27">Study dentists and patient blinding were not possible due to the intervention procedures of the study. However, to reduce the risk of bias in recording the primary outcome, the study adheres to the ROBINS-I tool for non-randomised -prospective clinical study (Sterne et al. <xref ref-type="bibr" rid="CR38">2016</xref>). Thus, the reassessment of the degree of hypersensitivity via SCASS following direct application of GIC sealant application (15 min) and in 12 weeks was performed not only by two principal investigators (RK &#x00026; MB) but also through an additional independent trained assessor (3 different paediatric dentists involved). In the rare case of a different assessment the SCASS score included for analysis was chosen by discussion and agreement between the examiners right after clinical evaluation.</p><p id="Par28">The modified United States Public Health Service (USPHS) clinical rating system was used for clinical evaluation of the GIC-sealants (Ionostar Plus &#x00026; Easy Glaze, VOCO) retention rate, marginal integrity, discoloration surface texture (optic and tactile) and presence of caries lesion at the follow-up visit scheduled after 12 weeks (Dukic et al., 2007).</p></sec><sec id="Sec6"><title>Intervention / procedure</title><p id="Par29">In each patient, the hypersensitive MIH tooth/teeth was/were sealed with a fast-setting radiopaque bulk-fill glass-ionomer filling material (Ionostar Plus, VOCO) followed by an application of a nano-filled, light-curing coating (Easy Glaze, VOCO) with a natural fluorescence for surface sealing.</p><p id="Par30">Before sealing, the hypersensitive MIH teeth were cleaned with prophylactic paste for tooth-cleaning (rophy paste, Henry Schein) using a bristle brush. The teeth were then isolated with cotton rolls and the glass-ionomer cement (Ionostar Plus, VOCO) was then applied after mixing the capsule for 10 s. Subsequently, the sealants were covered with a protective coat (Easy Glaze, VOCO) and cured for 30 s based on manufacturer instructions. Occlusion control was performed using articulating paper and adjustment of the GIC sealant were only done if it was necessary. The study procedures were done without the administration of local anaesthesia (LA).</p><p id="Par31">Finally, the patients were instructed to brush daily with fluoride containing toothpaste and use weekly a fluoride gel (12.500 ppm fluoride) as generally suggested for patients with high caries risk in the department (AAPD, <xref ref-type="bibr" rid="CR3">2023</xref>).</p></sec><sec id="Sec7"><title>Data analysis</title><p id="Par32">The data were initially summarised descriptively, and the mean value and standard deviation were calculated. The mean SCASS and WBFS between different time periods were compared using <italic>t</italic> test. Whereas, the difference between measurements at different time points was calculated using the Mann&#x02013;Whitney <italic>U</italic> Test. The inter-examiner reliability was calculated using Cohen&#x02019;s Kappa test. The inter-examiner reliability for reassessing the degree of hypersensitivity via SCASS scores directly after the application (15 min) and in 3 months&#x02019; period via the study dentists and independent examiner was 0.80. In case of disagreement, a consensus scoring was made. All statistical tests were performed with the Excel 2016 program (Excel, Microsoft). In this study, a <italic>P</italic>&#x02009;&#x0003e;&#x02009;0.05 was considered to be statistically significant.</p></sec></sec><sec id="Sec8"><title>Results</title><p id="Par33">After screening and assessing the eligibility to participate in the study, 25 patients (mean age 8.6&#x02009;&#x000b1;&#x02009;1.85, 56% females) with a total number of 43 teeth were included in this prospective study. The patients had a mean dmft/DMFT of 2.46 (&#x000b1;&#x02009;3.06)/0.80 (&#x000b1;&#x02009;0.87). An average number of&#x02009;~&#x02009;1.7 teeth with high intensity of hypersensitivity (SCASS&#x02009;&#x02265;&#x02009;2) were included in MIH-affected patients as shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.</p><p id="Par34">Table <xref rid="Tab2" ref-type="table">2</xref> shows the general baseline characteristics on tooth level. More than half of the hypersensitive MIH molars (<italic>n</italic>&#x02009;=&#x02009;26, 60.5%) were upper right (16) and lower left (46) permanent molars and a SCASS score of 3 (<italic>n</italic>&#x02009;=&#x02009;24, 55.8%). A total number of 30 teeth (69.8%) had entirely no history of prior in-office desensitising treatment, the other ones (<italic>n</italic>&#x02009;=&#x02009;13, 31.2%) had but more than 1 month before study enrolment. Previous treatments included e.g. silver diamine fluoride, glass-ionomer cement or composite fillings (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>General baseline characteristic of the study sample (Patient level; n&#x02009;=&#x02009;25)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Patient variable</th><th align="left" colspan="2">Category</th></tr></thead><tbody><tr><td align="left" rowspan="2">Age (in years)</td><td align="left">Mean(&#x000b1;&#x02009;SD)</td><td align="left">8.6&#x02009;&#x000b1;&#x02009;1.85</td></tr><tr><td align="left">Min&#x02013;Max</td><td align="left">6.2&#x02013;11.7</td></tr><tr><td align="left" rowspan="2">Sex</td><td align="left">Males</td><td align="left">11 (44.0%)</td></tr><tr><td align="left">Females</td><td align="left">14 (56.0%)</td></tr><tr><td align="left" rowspan="2">Dmft</td><td align="left">Mean(&#x000b1;&#x02009;SD)</td><td align="left">2.46 (&#x000b1;&#x02009;3.06)</td></tr><tr><td align="left">Min&#x02013;Max</td><td align="left">0.00&#x02013;9.00</td></tr><tr><td align="left" rowspan="2">DMFT</td><td align="left">Mean(&#x000b1;&#x02009;SD)</td><td align="left">0.80 (&#x000b1;&#x02009;0.87)</td></tr><tr><td align="left">Min&#x02013;Max</td><td align="left">0.00&#x02013;3.00</td></tr><tr><td align="left">Mean follow-up time (for scheduled 12&#x000a0;weeks follow-up; Weeks)</td><td align="left">Mean(&#x000b1;&#x02009;SD)</td><td align="left">16.3 (&#x000b1;&#x02009;5.0)</td></tr><tr><td align="left" rowspan="2">Number of hypersensitive MIH molars per patient receiving GIC application</td><td align="left">Mean(&#x000b1;&#x02009;SD)</td><td align="left">1.72 (&#x000b1;&#x02009;1.02)</td></tr><tr><td align="left">Min&#x02013;Max</td><td align="left">1.00&#x02013;4.00</td></tr></tbody></table><table-wrap-foot><p><italic>SD</italic> Standard deviation, <italic>Min</italic> Minimum, <italic>Max</italic> Maximum</p></table-wrap-foot></table-wrap></p><p id="Par35">The intensity of the hypersensitivity was evaluated via SCASS and WBFS at different time points (baseline, 15 min and 12 weeks post-application) as shown in Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref> and <xref rid="Tab4" ref-type="table">4</xref>. According to the study results, a statistical significant reduction in the degree of hypersensitivity was observed in all 25 patients immediately (15 min post application) and 12 weeks measured with SCASS as well as WBFS (<italic>P</italic>&#x02009;&#x0003c;&#x02009;<italic>0.001, paired t test).</italic> The mean SCASS scores decreased significantly immediately following GIC application (Ionostar Plus &#x00026; Easy Glaze, VOCO) to 1.14 (&#x000b1;&#x02009;0.96) and to 0.71 (&#x000b1;&#x02009;0.89) after 12 weeks (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref> and <xref rid="Tab4" ref-type="table">4</xref>). Moreover, the mean WBFS scores also significantly decreased to 3.00 (&#x000b1;&#x02009;2.28) after 15 min and basically stayed constant with a mean value of 2.95 (&#x000b1;&#x02009;2.17) when the child was asked after air stimulus in the 12 week follow-up (Table<xref rid="Tab5" ref-type="table">5</xref>).<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>General baseline characteristic of the study sample (tooth level; <italic>n</italic>&#x02009;=&#x02009;43)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Category</th><th align="left" colspan="5">Tooth distribution (included hypersensitive MIH molar)</th><th align="left" rowspan="2">Total<break/><italic>N</italic> (%)</th></tr><tr><th align="left">Criteria</th><th align="left">#16</th><th align="left">#26</th><th align="left">#36</th><th align="left">#46</th><th align="left">#17</th></tr></thead><tbody><tr><td align="left" colspan="7">MIH-TNI score</td></tr><tr><td align="left">&#x000a0;3</td><td align="left">8 (66.6%)</td><td align="left">4 (57.1%)</td><td align="left">2 (22.2%)</td><td align="left">5 (35.7%)</td><td align="left">&#x02013;</td><td align="left">19 (44.1%)</td></tr><tr><td align="left">&#x000a0;4a</td><td align="left">4 (44.4%)</td><td align="left">2 (28.6%)</td><td align="left">5 (55.6%)</td><td align="left">5 (35.7%)</td><td align="left">&#x02013;</td><td align="left">16 (37.2%)</td></tr><tr><td align="left">&#x000a0;4b</td><td align="left">&#x02013;</td><td align="left">1 (14.3%)</td><td align="left">2 (22.2%)</td><td align="left">4 (28.6%)</td><td align="left">1 (100%)</td><td align="left">8 (18.6%)</td></tr><tr><td align="left">&#x000a0;4c</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td></tr><tr><td align="left">Total</td><td align="left">12 (27.9%)</td><td align="left">7 (16.3%)</td><td align="left">9 (20.1%)</td><td align="left">14 (33.5%)</td><td align="left">1 (2.3%)</td><td align="left">43 (100%)</td></tr><tr><td align="left" colspan="7">Baseline SCASS</td></tr><tr><td align="left">&#x000a0;2</td><td align="left">6 (50.0%)</td><td align="left">2 (28.6%)</td><td align="left">2 (22.2%)</td><td align="left">9 (64.3%)</td><td align="left">&#x02013;</td><td align="left">19 (44.2%)</td></tr><tr><td align="left">&#x000a0;3</td><td align="left">6 (50.0%)</td><td align="left">5 (71.4%)</td><td align="left">7 (77.8%)</td><td align="left">5 (35.7%)</td><td align="left">1 (100%)</td><td align="left">24 (55.8%)</td></tr><tr><td align="left">Total</td><td align="left">12 (27.9%)</td><td align="left">7 (16.3%)</td><td align="left">9 (20.1%)</td><td align="left">14 (32.5%)</td><td align="left">1 (2.3%)</td><td align="left">43 (100%)</td></tr><tr><td align="left" colspan="7"><p>Prior desensitising treatment</p><p>(&#x0003e;&#x02009;1 month before study enrolment)</p></td></tr><tr><td align="left">&#x000a0;N/A</td><td align="left">9 (75.0%)</td><td align="left">6 (85.7%)</td><td align="left">5 (55.6%)</td><td align="left">9 (64.2%)</td><td align="left">1 (100%)</td><td align="left">30 (69.8%)</td></tr><tr><td align="left">&#x000a0;SDF</td><td align="left">1 (8.3%)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">1 (7.1%)</td><td align="left">&#x02013;</td><td align="left">2 (4.7%)</td></tr><tr><td align="left">&#x000a0;Flg</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">1 (11.1%)</td><td align="left">1 (7.1%)</td><td align="left">&#x02013;</td><td align="left">2 (4.7%)</td></tr><tr><td align="left">&#x000a0;GIC</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">2 (22.2%)</td><td align="left">3 (21.4%)</td><td align="left">&#x02013;</td><td align="left">5 (11.6%)</td></tr><tr><td align="left">&#x000a0;GIC&#x02009;+&#x02009;Flg</td><td align="left">1 (8.3%)</td><td align="left">&#x02013;</td><td align="left">1 (11.1%)</td><td align="left">-</td><td align="left">&#x02013;</td><td align="left">2 (4.7%)</td></tr><tr><td align="left">&#x000a0;GIC&#x02009;+&#x02009;SDF</td><td align="left">1 (8.4%)</td><td align="left">1 (14.2%)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left">2 (4.7%)</td></tr><tr><td align="left">Total</td><td align="left">12 (27.9%)</td><td align="left">7 (16.3%)</td><td align="left">9 (20.1%)</td><td align="left">14 (32.5%)</td><td align="left">1 (2.3%)</td><td align="left">43 (100%)</td></tr></tbody></table><table-wrap-foot><p><italic>SDF</italic> Silver-diamine fluoride, <italic>GIC</italic> Glass-ionomer cement, <italic>Flg</italic>: Composite filling, <italic>N/A</italic> Not applicable</p></table-wrap-foot></table-wrap><table-wrap id="Tab4"><label>Table&#x000a0;4</label><caption><p>Comparison of SCASS scores at baseline and after 15 min &#x00026; 12 weeks post application of GIC on hypersensitive MIH molars (tooth level; <italic>n</italic>&#x02009;=&#x02009;43; Drop-out, <italic>n</italic>&#x02009;=&#x02009;1)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">SCASS score</th><th align="left">Baseline</th><th align="left">15 min</th><th align="left">12 weeks</th><th align="left">Paired&#x000a0;<italic>t</italic>&#x000a0;test</th></tr><tr><th align="left" colspan="3"><italic>N</italic> (%)</th><th align="left"><italic>P</italic> value&#x000a0;</th></tr></thead><tbody><tr><td align="left">0</td><td align="left">&#x02013;</td><td align="left">13 (30.2%)</td><td align="left">22 (52.4%)</td><td align="left" rowspan="8"><italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001*</td></tr><tr><td align="left">1</td><td align="left">&#x02013;</td><td align="left">15 (34.9%)</td><td align="left">12 (28.5%)</td></tr><tr><td align="left">2</td><td align="left">19 (44.2%)</td><td align="left">11 (25.6%)</td><td align="left">6 (14.3%)</td></tr><tr><td align="left">3</td><td align="left">24 (55.8%)</td><td align="left">4 (9.3%)</td><td align="left">2 (4.7%)</td></tr><tr><td align="left">Mean (SD)</td><td align="left">2.56 (&#x000b1;&#x02009;0.50)</td><td align="left">1.14 (&#x000b1;&#x02009;0.96)</td><td align="left"><bold>0.71 (&#x000b1;&#x02009;0.89)</bold></td></tr><tr><td align="left">Median (IQR)</td><td align="left">3.00 (2.00, 3.00)</td><td align="left">1.00 (1.00, 2.00)</td><td align="left"><bold>0.00 (0.00, 1.00)</bold></td></tr><tr><td align="left" rowspan="2">Difference (15 min&#x02013;baseline)</td><td align="left" colspan="3">Mean (SD)&#x02009;= &#x02212;&#x000a0;1.42 (0.46)</td></tr><tr><td align="left" colspan="3">Median (IQR)&#x02009;= &#x02212;&#x000a0;2.00 (&#x02212;&#x000a0;1.00, &#x02212;&#x000a0;1.00)</td></tr><tr><td align="left" rowspan="2">Difference (12 weeks&#x02013;baseline)</td><td align="left" colspan="3">Mean (SD)&#x02009;= &#x02212;&#x000a0;1.85 (0.39)</td><td align="left" rowspan="2"><italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001*</td></tr><tr><td align="left" colspan="3">Median (IQR)&#x02009;= &#x02212;&#x000a0;3.00 (&#x02212;&#x000a0;2.00, &#x02212;&#x000a0;2.00)</td></tr><tr><td align="left" rowspan="2">Difference (15 min&#x02013;12 weeks)</td><td align="left" colspan="3">Mean (SD)&#x02009;= &#x02212;&#x000a0;0.44 (0.09)</td><td align="left" rowspan="2">4&#x02009;&#x0003c;&#x02009;0.01*</td></tr><tr><td align="left" colspan="3">Median (IQR)&#x02009;= &#x02212;&#x000a0;1.00 (&#x02212;&#x000a0;1.00, &#x02212;&#x000a0;1.00)</td></tr></tbody></table><table-wrap-foot><p><italic>SCASS</italic> Schiff cold air sensitivity test, <italic>SD</italic> Standard deviation, <italic>IQR</italic> Interquartile range, Paired t test was used. *statistically significant at <italic>p</italic> value&#x02009;&#x0003c;&#x02009;0.05</p></table-wrap-foot></table-wrap><table-wrap id="Tab5"><label>Table&#x000a0;5</label><caption><p>Comparison of WBFS scores at baseline and after 15 min &#x00026; 12 weeks post application of GIC on hypersensitive MIH molars (tooth level; <italic>n</italic>&#x02009;=&#x02009;43; Drop-out, <italic>n</italic>&#x02009;=&#x02009;1)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">WBFS score</th><th align="left">Baseline</th><th align="left">15 min</th><th align="left">12 weeks</th><th align="left">Paired&#x000a0;<italic>t</italic>&#x000a0;test&#x000a0;</th></tr><tr><th align="left" colspan="3"><italic>N</italic> (%)</th><th align="left"><italic>P</italic> value&#x000a0;</th></tr></thead><tbody><tr><td align="left">&#x02009;&#x02264;&#x02009;4</td><td align="left">15 (34.9%)</td><td align="left">37 (86.2%)</td><td align="left">35 (83.4%)</td><td align="left" rowspan="6"><italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01*</td></tr><tr><td align="left">&#x02009;&#x02265;&#x02009;6</td><td align="left">28 (65.10%)</td><td align="left">6 (13.8%)</td><td align="left">7 (16.6%)</td></tr><tr><td align="left">Mean (SD)</td><td align="left">5.86 (&#x000b1;&#x02009;2.50)</td><td align="left">3.00 (&#x000b1;&#x02009;2.28)</td><td align="left">2.95 (&#x000b1;&#x02009;2.17)</td></tr><tr><td align="left">Median (IQR)</td><td align="left">6.00 (4.00, 8.00)</td><td align="left">2.00 (2.00, 4.00)</td><td align="left">4.00 (2.00, 4.00)</td></tr><tr><td align="left" rowspan="2">Difference (15 min&#x02013;baseline)</td><td align="left" colspan="3">Mean (SD)&#x02009;= &#x02212;&#x000a0;2.86 (0.22)</td></tr><tr><td align="left" colspan="3">Median (IQR)&#x02009;= &#x02212;&#x000a0;4.00 (&#x02212;&#x000a0;2.00, &#x02212;&#x000a0;4.00)</td></tr><tr><td align="left" rowspan="2">Difference (12 weeks&#x02013;baseline)</td><td align="left" colspan="3">Mean (SD)&#x02009;=&#x02009;&#x02212;&#x000a0;2.91 (0.33)</td><td align="left" rowspan="2"><italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01*</td></tr><tr><td align="left" colspan="3">Median (IQR)&#x02009;=&#x02009;&#x02212;&#x000a0;2.00 (&#x02212;&#x000a0;2.00, &#x02212;&#x000a0;4.00)</td></tr><tr><td align="left" rowspan="2">Difference (15 min&#x02013;12 weeks)</td><td align="left" colspan="3">Mean (SD)&#x02009;= &#x02212;&#x000a0;0.05 (0.11)</td><td align="left" rowspan="2"><italic>P</italic>&#x02009;&#x0003e;&#x02009;0.05</td></tr><tr><td align="left" colspan="3">Median (IQR)&#x02009;=&#x02009;2.00 (0.00, 0.00)</td></tr></tbody></table><table-wrap-foot><p><italic>WBFS</italic> Wong-Baker Facial Scale, <italic>SD</italic> Standard deviation, <italic>IQR</italic> Interquartile range, Paired t test was used. *statistically significant at p value&#x02009;&#x0003c;&#x02009;0.0</p></table-wrap-foot></table-wrap></p><p id="Par36">Furthermore, hypersensitive MIH molars with a baseline SCASS score of 2 &#x00026; 3 showed a significant reduction in the hypersensitivity both immediately (15 min) and after 12 weeks after application of the GIC sealant (<italic>P</italic>&#x02009;=&#x02009;<italic>0.01, Mann&#x02013;Whitney U test</italic>). According to the study results, no significant difference (P&#x02009;=&#x02009;0.06**) in the extent of the immediate hypersensitivity relief (15 min after the application of GIC (Ionostar Plus&#x02009;+&#x02009;Easy Glaze, VOCO) between MIH molars of a baseline SCASS 2 vs. SCASS 3 (<italic>P</italic>&#x02009;=&#x02009;<italic>0.06, t test) was achieved</italic> (Table&#x000a0;<xref rid="Tab6" ref-type="table">6</xref>). However, the hypersensitivity of MIH molars with baseline SCASS score 2 was reduced significantly more than those of a baseline SCASS score 3 in the time period of 3 months (mean SCASS reduction&#x02009;&#x000b1;&#x02009;SD: &#x02212;&#x000a0;1.96&#x02009;&#x000b1;&#x02009;0.41 vs. &#x02212;&#x000a0;1.68&#x02009;&#x000b1;&#x02009;0.41; Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref>).<table-wrap id="Tab6"><label>Table&#x000a0;6</label><caption><p>Comparison of SCASS scores after 15 min and 12 weeks post treatment with GIC differentiated by baseline SCASS score (2 vs. 3) molars (tooth level; <italic>n</italic>&#x02009;=&#x02009;43; Drop-out, <italic>n</italic>&#x02009;=&#x02009;1)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">15 min post-treatment SCASS score</th><th align="left">Baseline SCASS 2 (<italic>n</italic>&#x02009;=&#x02009;19; 44.2%)</th><th align="left">Baseline SCASS 3 (<italic>n</italic>&#x02009;=&#x02009;24; 55.8%)</th><th align="left"><italic>P</italic> value</th></tr><tr><th align="left" colspan="2">N (%)</th><th align="left"/></tr></thead><tbody><tr><td align="left">0</td><td align="left">7 (36.8%)</td><td align="left">6 (25.0%)</td><td align="left" rowspan="6"><italic>P</italic>&#x02009;=&#x02009;0.01*</td></tr><tr><td align="left">1</td><td align="left">10 (52.6%)</td><td align="left">5 (20.8%)</td></tr><tr><td align="left">2</td><td align="left">2 (10.5%)</td><td align="left">9 (37.5%)</td></tr><tr><td align="left">3</td><td align="left">&#x02013;</td><td align="left">4 (16.7%)</td></tr><tr><td align="left">Mean (&#x000b1;&#x02009;SD)</td><td align="left">0.74 (&#x000b1;&#x02009;0.98)</td><td align="left">1.46 (&#x000b1;&#x02009;0.95)</td></tr><tr><td align="left">Median (IQR)</td><td align="left">1.00 (0.00, 1.00)</td><td align="left">1.00 (1.00, 2.00)</td></tr><tr><td align="left" colspan="4">Difference</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">&#x02212;&#x000a0;1.26 (&#x000b1;&#x02009;0.48)</td><td align="left">&#x02212;&#x000a0;1.54 (&#x000b1;&#x02009;0.46)</td><td align="left" rowspan="2"><italic>P</italic>&#x02009;=&#x02009;0.06**</td></tr><tr><td align="left">&#x000a0;Median (IQR)</td><td align="left">&#x02212;&#x000a0;1.00 (&#x02212;&#x000a0;2.00, &#x02212;&#x000a0;1.00)</td><td align="left">&#x02212;&#x000a0;2.00 (&#x02212;&#x000a0;2.00, &#x02212;&#x000a0;1.00)</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">12 weeks post-treatment SCASS score</th><th align="left">Baseline SCASS 2<break/>(<italic>n</italic>&#x02009;=&#x02009;19; 44.2%)</th><th align="left">Baseline SCASS 3<break/>(<italic>n</italic>&#x02009;=&#x02009;23; 55.8%)</th><th align="left" rowspan="2"><italic>P</italic> value</th></tr><tr><th align="left" colspan="2">N (%)</th></tr></thead><tbody><tr><td align="left">0</td><td align="left">13 (68.4%)</td><td align="left">9 (39.1%)</td><td align="left" rowspan="6"><italic>P</italic>&#x02009;=&#x02009;0.03*</td></tr><tr><td align="left">1</td><td align="left">6 (31.6%)</td><td align="left">6 (26.1%)</td></tr><tr><td align="left">2</td><td align="left">&#x02013;</td><td align="left">6 (26.1%)</td></tr><tr><td align="left">3</td><td align="left">&#x02013;</td><td align="left">2 (8.7%)</td></tr><tr><td align="left">Mean (&#x000b1;&#x02009;SD)</td><td align="left">0.32 (&#x000b1;&#x02009;0.91)</td><td align="left">1.04 (&#x000b1;&#x02009;0.90)</td></tr><tr><td align="left">Median (IQR)</td><td align="left">0.00 (0.00, 1.00)</td><td align="left">1.00 (0.00, 1.00)</td></tr><tr><td align="left" colspan="4">Difference</td></tr><tr><td align="left">&#x000a0;Mean (SD)</td><td align="left">&#x02212;&#x000a0;1.68 (&#x000b1;&#x02009;0.41)</td><td align="left">&#x02212;&#x000a0;1.96 (&#x000b1;&#x02009;0.41)</td><td align="left" rowspan="2"><italic>P</italic>&#x02009;=&#x02009;0.03**</td></tr><tr><td align="left">&#x000a0;Median (IQR)</td><td align="left">&#x02212;&#x000a0;1.00 (&#x02212;&#x000a0;2.00, &#x02212;&#x000a0;1.00)</td><td align="left">&#x02212;&#x000a0;2.00 (&#x02212;&#x000a0;2.00, &#x02212;&#x000a0;1.00)</td></tr></tbody></table><table-wrap-foot><p><italic>SCASS</italic> Schiff cold air sensitivity test; <italic>SD</italic> Standard deviation, <italic>IQR</italic> Interquartile range, <italic>MWU</italic>
<sup>*</sup>Mann&#x02013;Whitney U test was used. **<italic>t</italic> test. statistically significant at <italic>p</italic> value&#x02009;&#x0003c;&#x02009;0.05</p></table-wrap-foot></table-wrap></p><p id="Par37">In addition, a similar reduction in the intensity of hypersensitivity was observed in hypersensitive MIH molars with and without a history of in-office desensitising pre-treatment after 15 min within the GIC application (<italic>P</italic>&#x02009;=&#x02009;<italic>0.62, Mann&#x02013;Whitney U test)</italic> and in 12 week&#x02019;s revaluation (<italic>P</italic>&#x02009;=&#x02009;<italic>0.31, Mann&#x02013;Whitney U test)</italic> as shown in Table&#x000a0;<xref rid="Tab7" ref-type="table">7</xref>. Furthermore, there were no significant differences in mean SCASS reductions between both groups immediately after application for teeth without pre-treatment history (&#x02212;&#x000a0;0.92 (&#x000b1;&#x02009;0.73) vs. &#x02212;&#x000a0;1.33 (&#x000b1;&#x02009;0.22)<italic>, P</italic>&#x02009;=&#x02009;<italic>0.11, t test</italic>) and after 12 week&#x02019;s follow-up for pre-treatment and without pretreatment (&#x02212;&#x000a0;1.61 (&#x000b1;&#x02009;0.38) vs. &#x02212;&#x000a0;1.38 (&#x000b1;&#x02009;0.55), P&#x02009;=&#x02009;0.35, <italic>t test</italic>) as shown above in Table&#x000a0;<xref rid="Tab7" ref-type="table">7</xref>. Though in this study, hypersensitive MIH molars with a history of pre-treatment (<italic>n</italic>&#x02009;=&#x02009;13) showed a statistically significant higher reduction in mean SCASS, when compared between immediate effect (15 min) and 12 weeks follow-up (&#x02212;&#x000a0;0.69 (&#x000b1;&#x02009;0.35) vs. &#x02212;&#x000a0;0.05 (&#x000b1;&#x02009;0.12) <italic>P</italic>&#x02009;&#x0003c;&#x02009;<italic>0.01</italic>, <italic>t test</italic>).<table-wrap id="Tab7"><label>Table&#x000a0;7</label><caption><p>Comparison of SCASS scores differentiated by prior treatment in MIH molars (tooth level; <italic>n</italic>&#x02009;=&#x02009;43; Drop-out, <italic>n</italic>&#x02009;=&#x02009;1)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="2"/><th align="left">Pre-treatment (<italic>n</italic>&#x02009;=&#x02009;13)</th><th align="left">No pre-treatment (<italic>n</italic>&#x02009;=&#x02009;30)</th><th align="left" rowspan="2"><italic>P</italic> value&#x000a0;</th></tr><tr><th align="left" colspan="2"><italic>N</italic> (%)</th></tr></thead><tbody><tr><td align="left" colspan="5">Baseline SCASS</td></tr><tr><td align="left" colspan="2">&#x000a0;0</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left" rowspan="6"><italic>P</italic>&#x02009;=&#x02009;0.07*</td></tr><tr><td align="left" colspan="2">&#x000a0;1</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td></tr><tr><td align="left" colspan="2">&#x000a0;2</td><td align="left">9 (40.9%)</td><td align="left">10 (54.8%)</td></tr><tr><td align="left" colspan="2">&#x000a0;3</td><td align="left">4 (59.1%)</td><td align="left">20 (45.2%)</td></tr><tr><td align="left" colspan="2">&#x000a0;Mean (&#x000b1;&#x02009;SD)</td><td align="left">2.30 (&#x000b1;&#x02009;0.48)</td><td align="left">2.45 (&#x000b1;&#x02009;0.51)</td></tr><tr><td align="left" colspan="2">&#x000a0;Median (IQR)</td><td align="left">3.00 (2.00, 3.00)</td><td align="left">2.00 (2.00, 3.00)</td></tr><tr><td align="left" colspan="5">15 min SCASS</td></tr><tr><td align="left" colspan="2">&#x000a0;0</td><td align="left">4 (36.4%)</td><td align="left">9 (12.9%)</td><td align="left" rowspan="6"><italic>P</italic>&#x02009;=&#x02009;0.62*</td></tr><tr><td align="left" colspan="2">&#x000a0;1</td><td align="left">4 (31.8%)</td><td align="left">9 (12.9%)</td></tr><tr><td align="left" colspan="2">&#x000a0;2</td><td align="left">1 (18.2%)</td><td align="left">9 (12.9%)</td></tr><tr><td align="left" colspan="2">&#x000a0;3</td><td align="left">4 (13.6%)</td><td align="left">9 (12.9%)</td></tr><tr><td align="left" colspan="2">&#x000a0;Mean (SD)</td><td align="left">1.38 (&#x000b1;&#x02009;1.21)</td><td align="left">9 (12.9%)</td></tr><tr><td align="left" colspan="2">&#x000a0;Median (IQR)</td><td align="left">1.00 (0.00, 2.00)</td><td align="left">1.00 (0.00, 2.00)</td></tr><tr><td align="left" colspan="5">12 weeks SCASS (Drop-out; n&#x02009;=&#x02009;1)</td></tr><tr><td align="left" colspan="2">&#x000a0;0</td><td align="left">7 (53.8%)</td><td align="left">11 (37.9%)</td><td align="left" rowspan="6"><italic>P</italic>&#x02009;=&#x02009;0.31*</td></tr><tr><td align="left" colspan="2">&#x000a0;1</td><td align="left">3 (23.1%)</td><td align="left">9 (31.3%)</td></tr><tr><td align="left" colspan="2">&#x000a0;2</td><td align="left">3 (23.1%)</td><td align="left">5 (17.2%)</td></tr><tr><td align="left" colspan="2">&#x000a0;3</td><td align="left">-</td><td align="left">4 (13.7%)</td></tr><tr><td align="left" colspan="2">&#x000a0;Mean (SD)</td><td align="left">0.69 (&#x000b1;&#x02009;0.86)</td><td align="left">1.07 (&#x000b1;&#x02009;1.06)</td></tr><tr><td align="left" colspan="2">&#x000a0;Median (IQR)</td><td align="left">1.00 (0.00, 1.00)</td><td align="left">1.00 (0.00, 1.00)</td></tr><tr><td align="left" colspan="5">Difference Baseline&#x02014;15 min</td></tr><tr><td align="left" colspan="2">&#x000a0;Mean (SD)</td><td align="left">&#x02212;&#x000a0;0.92 (&#x000b1;&#x02009;0.73)</td><td align="left">&#x02212;&#x000a0;1.33 (&#x000b1;&#x02009;0.22)</td><td align="left" rowspan="2"><italic>P</italic>&#x02009;=&#x02009;0.11**</td></tr><tr><td align="left" colspan="2">&#x000a0;Median (IQR)</td><td align="left">&#x02212;&#x000a0;2.00 (&#x02212;&#x000a0;2.00, &#x02212;&#x000a0;1.00)</td><td align="left">&#x02212;&#x000a0;1.00 (&#x02212;&#x000a0;2.00, &#x02212;&#x000a0;1.00)</td></tr><tr><td align="left" colspan="5">Difference Baseline&#x02014;12 weeks</td></tr><tr><td align="left" colspan="2">&#x000a0;Mean (SD)</td><td align="left">&#x02212;&#x000a0;1.61 (&#x000b1;&#x02009;0.38)</td><td align="left">&#x02212;&#x000a0;1.38 (&#x000b1;&#x02009;0.55)</td><td align="left" rowspan="2"><italic>P</italic>&#x02009;=&#x02009;0.35**</td></tr><tr><td align="left" colspan="2">&#x000a0;Median (IQR)</td><td align="left">&#x02212;&#x000a0;2.00 (&#x02212;&#x000a0;2.00, &#x02212;&#x000a0;2.00)</td><td align="left">&#x02212;&#x000a0;1.00 (&#x02212;&#x000a0;2.00, &#x02212;&#x000a0;2.00)</td></tr><tr><td align="left" colspan="5">Difference 15 min&#x02014;12 weeks</td></tr><tr><td align="left" colspan="2">&#x000a0;Mean (SD)</td><td align="left">&#x02212;&#x000a0;0.69 (&#x000b1;&#x02009;0.35)</td><td align="left">&#x02212;&#x000a0;0.05 (&#x000b1;&#x02009;0.12)</td><td align="left" rowspan="2"><bold><italic>P</italic></bold><bold>&#x02009;&#x0003c;&#x02009;</bold><bold><italic>0.01</italic></bold>**</td></tr><tr><td align="left" colspan="2">&#x000a0;Median (IQR)</td><td align="left">0.00 (0.00, &#x02212;&#x000a0;1.00)</td><td align="left">0.00 (0.00, &#x02212;&#x000a0;1.00)</td></tr></tbody></table><table-wrap-foot><p><italic>SCASS</italic> Schiff cold air sensitivity test, <italic>SD</italic> Standard deviation, <italic>IQR</italic> Interquartile range, *<italic>MWU</italic> Mann&#x02013;Whitney U test was used, **<italic>t</italic> test was used. statistically significant at <italic>p</italic> value&#x02009;&#x0003c;&#x02009;0.05</p></table-wrap-foot></table-wrap></p><p id="Par38">The performance of the GIC sealant (Ionostar Plus &#x00026; Easy Glaze, VOCO) was assessed (Table<xref rid="Tab8" ref-type="table">&#x000a0;8</xref>) using modified USPHS criteria via the study examiners (xx &#x00026; xx) in the 12 weeks follow-up. Twenty hypersensitive MIH molars were sealed in the upper jaw and twenty-two molars in the lower jaw, one patient (<italic>n</italic>&#x02009;=&#x02009;1) was excluded from the analysis due to no-show in a follow-up appointment (Drop-out <italic>n</italic>&#x02009;=&#x02009;1). A complete loss of the GIC sealing occurred in 3 (7.2%) teeth over 12 weeks. Regarding marginal discoloration without penetration to the pulp, this event was observed in 8 teeth (19.0%) after 12 weeks. Whereas, the majority of the GIC sealant (<italic>n</italic>&#x02009;=&#x02009;34, 80.9%) retained a shiny surface texture and only 3 (7.2%) GIC sealant had a rough surface texture. Furthermore, the sealing deteriorations occurred mainly in three domains, which were marginal integrity, and optical as well as tactile surface texture (Table&#x000a0;<xref rid="Tab8" ref-type="table">8</xref>).<table-wrap id="Tab8"><label>Table&#x000a0;8</label><caption><p>Clinical scores of the restorations in both groups according to the modified USPHS criteria after 12 weeks post application of GIC on hypersensitive MIH molars (tooth level; n&#x02009;=&#x02009;43; Drop-out, n&#x02009;=&#x02009;1)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"><italic>N</italic>&#x02009;=&#x02009;43</th><th align="left" colspan="3">Baseline</th><th align="left" colspan="3">12 weeks</th><th align="left" rowspan="2">Total sealings evaluated</th></tr><tr><th align="left">A*</th><th align="left">B*</th><th align="left">C**</th><th align="left">A*</th><th align="left">B**</th><th align="left">C***</th></tr></thead><tbody><tr><td align="left">Retention</td><td align="left">42 (100%)</td><td align="left" rowspan="6"/><td align="left" rowspan="6"/><td align="left">24 (57.3%)</td><td align="left">14 (33.5%)</td><td align="left">3 (7.2%)</td><td align="left" rowspan="6">42 (97.6%)</td></tr><tr><td align="left">Marginal integrity</td><td align="left">42 (100%)</td><td align="left">19 (45.2%)</td><td align="left">23 (54.8%)</td><td align="left">7 (16.6%)</td></tr><tr><td align="left">Marginal discoloration</td><td align="left">42 (100%)</td><td align="left">33 (78.6%)</td><td align="left">8 (19.0%)</td><td align="left">1 (2.4%)</td></tr><tr><td align="left">Surface texture- optical</td><td align="left">42 (100%)</td><td align="left">34 (80.9%)</td><td align="left">8 (19.0%)</td><td align="left">0 (0.0%)</td></tr><tr><td align="left">Surface texture- tactile</td><td align="left">42 (100%)</td><td align="left">27 (64.2%)</td><td align="left">12 (28.6%)</td><td align="left">3 (7.1%)</td></tr><tr><td align="left">Caries</td><td align="left">42 (100%)</td><td align="left">40 (95.2%)</td><td align="left">2 (4.8%)</td><td align="left">&#x02013;</td></tr></tbody></table><table-wrap-foot><p>A&#x02009;=&#x02009;Alpha, B&#x02009;=&#x02009;Bravo, C&#x02009;=&#x02009;Charlie</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec9"><title>Discussion</title><p id="Par39">Molar-incisor hypomineralisation (MIH) is a delimited qualitative developmental defect, which is known to be associated with several dental complications like hypersensitivity, increased caries risk, and aesthetic impairment leading to a significant reduction in OHRQoL (Solinas et al. <xref ref-type="bibr" rid="CR37">2021</xref>). Up-to-date, several clinical trials have been conducted recently to evaluate the remineralisation and desensitising effect of various products e.g. fluoride varnish, casein-amorphous calcium phosphate (CPP-ACP), hydroxyapatite containing and arginine containing toothpastes in addition to silver diamine modified atraumatic restorative technique (SMART) and sealant application (Bakkal et al. <xref ref-type="bibr" rid="CR6">2017</xref>; Biondi et al. <xref ref-type="bibr" rid="CR14">2017</xref>; Restrepo et al. <xref ref-type="bibr" rid="CR34">2016</xref>). Though the management of hypersensitivity is still a huge challenge in daily practice (Rapaso et al.,<xref ref-type="bibr" rid="CR33">2019</xref>). Thus, this clinical prospective study provides more insight and evidence on the management and the extend of hypersensitivity reduction in MIH molars with and without enamel breakdown (MIH TNI- 3 &#x00026; 4).</p><p id="Par40">This study involved 25 patients with a mean age of 8.6 (&#x000b1;&#x02009;1.85) years, which is slightly higher than those of a similar previous study as shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> (Bekes et al. <xref ref-type="bibr" rid="CR10">2022</xref>). This might be explained by the fact that this study included not only newly erupted hypersensitive MIH molars but also patients with persisting hypersensitivity after prior desensitising treatments and one adolescent patient with 2nd permanent molar. The presence of enamel hypomineralisation on the second permanent molar is not unusual, this can be supported by the finding of a previous study, which concluded that the occurrence of enamel hypomineralization in the permanent second molar is generally more prevalent when the permanent first molar exhibits molar incisor hypomineralization (MIH) especially with severe defect (De Farias et al., <xref ref-type="bibr" rid="CR17">2021</xref>).</p><p id="Par41">The assessment of hypersensitivity is known to be subjective, which is difficult to measure. Evaporative stimuli (Schiff air cold sensitivity score) and visual analogue scale (VAS) are the most popular methods to induce and measure pain intensity in dentine hypersensitivity (Bijur et al. <xref ref-type="bibr" rid="CR13">2001</xref>). Since the pain intensity in the air test is higher the than tactile test, the Schiff air cold sensitivity score (SCASS) test was used as the primary outcome parameter in this study (Bekes et al. <xref ref-type="bibr" rid="CR12">2017</xref>). However, the additional subjective assessment of hypersensitivity was done using the Wong-baker faces scale (WBFS) instead of the visual analogue scale (VAS). This was decided as WBFS was originally created for children to communicate pain through facial expressions (Facial scales) and the most preferred way for children to report pain (Wong &#x00026; Baker, 1998; Keck et al. <xref ref-type="bibr" rid="CR23">1996</xref>). Furthermore, this study included children with a history of previous desensitising treatments, but no desensitising treatment should have been performed within 4 weeks. This can be explained by the assumption that a minimum period of 2&#x02013;4 weeks &#x0201c;wash-out phase&#x0201d; is required to eliminate or at least reduce the desensitising effect of a previously applied treatment (Vano et al. <xref ref-type="bibr" rid="CR39">2018</xref>).</p><p id="Par42">According to baseline characteristics of the study sample, a slightly higher number of hypersensitive lower molars were observed (<italic>n</italic>&#x02009;=&#x02009;20, 46.5% upper quadrants vs. <italic>n</italic>&#x02009;=&#x02009;23, 53.5% lower quadrants). This is similar to the observed characteristics of hypersensitive MIH-affected molars in a previous study (Bekes et al. <xref ref-type="bibr" rid="CR12">2017</xref>), whereas the slight majority of the included hypersensitive MIH molars were of high grade of sensitivity SCASS 3 (<italic>n</italic>&#x02009;=&#x02009;24, 55.8%) as shown in Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>. This supports the conclusion of previous findings, that hypersensitivity in MIH molars is significantly affected by the quality of mineralisation and degree of hypomineralisation rather than the size of the MIH defect (Linner et al. <xref ref-type="bibr" rid="CR26">2021</xref>). Hence, in this study hypersensitive MIH molars with and without enamel breakdown (MIH-TNI 3 &#x00026; 4a/b) were included.</p><p id="Par43">Regarding the degree of hypersensitivity and its pain intensity, the results of this study showed a mean SCASS of 2.56 (&#x000b1;&#x02009;0.50) and a mean WBFS of 5.86 (&#x000b1;&#x02009;2.50). This is similar to a previous study, which involved a mean SCASS of 2.4 (&#x000b1;&#x02009;0.50) but a higher mean of WBFS 7.1 (&#x000b1;&#x02009;1.7) as depicted in Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref> &#x00026; <xref rid="Tab4" ref-type="table">4</xref> (Bekes et al <xref ref-type="bibr" rid="CR10">2022</xref>). According to a previous epidemiological study, MIH molars of high intensity of hypersensitivity are mostly represented by maximum scores of SCASS (Raposo et al. <xref ref-type="bibr" rid="CR33">2019</xref>).</p><p id="Par44">This clinical trial was able to report a hypersensitivity relief, which is evident by a significant decrease (<italic>P</italic>&#x02009;&#x0003c;&#x02009;<italic>0.001, paired t test</italic><bold><italic>)</italic></bold> in the SCASS score, which reduced from 2.56 (&#x000b1;&#x02009;0.50) to 1.14 (&#x000b1;&#x02009;0.96) immediately after 15 min and even further to 0.71 (&#x000b1;&#x02009;0.89) in the following 12 weeks period as shown in Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>. A similar significant results were observed with a prolonged use of 8% arginine and calcium carbonate paste over 8 weeks, in which SCASS scores dropped from 2.1 (&#x000b1;&#x02009;0.3) to 0.8 (&#x000b1;&#x02009;0.9) (Bekes et al. <xref ref-type="bibr" rid="CR12">2017</xref>). Moreover, two other previous studies reported the use of an experimental paste based on zinc-hydroxyapatite which was shown to be effective in reducing hypersensitivity in MIH molars as well. They concluded the non-inferiority of a toothpaste containing microcrystalline hydroxyapatite compared to amino fluoride containing toothpaste (Ehlers et al. <xref ref-type="bibr" rid="CR19">2021</xref>; Butera et al. <xref ref-type="bibr" rid="CR15">2023</xref>). However, the major problem of hydroxyapatite-containing toothpaste is the lack of fluoride, which is known to be essential for caries prevention (AAPD, <xref ref-type="bibr" rid="CR3">2023</xref>). Importantly, this study involves assessing the effect of a single application of GIC sealant (Ionostar Plus&#x02009;+&#x02009;Easy Glaze, VOCO). Hence an assessment of immediate effect (15 min after application) was not only possible but showed a clear clinical benefit.</p><p id="Par45">In this study, for the majority of MIH molars the hypersensitivity SCASS score were reduced to&#x02009;&#x02264;&#x02009;1 immediately (15 min post application; 65.1%) and to a SCASS score of 0 over a period of 12 weeks (52.4%, Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). This means that the majority of patients (<italic>n</italic>&#x02009;=&#x02009;34, 80.9%) didn&#x02019;t show pain or hypersensitivity to the air stimulus anymore. This can be verified through the subjective assessment of pain intensity via WBFS, which showed a significant reduction in the mean WBFS score (<italic>P</italic>&#x02009;&#x0003c;&#x02009;<italic>0.01, paired t test, </italic>Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref><italic>)</italic> from 5.86 (&#x000b1;&#x02009;2.50) to immediately after the application of 3.00 (&#x000b1;&#x02009;2.28) and after 3 months to 2.95 (&#x000b1;&#x02009;2.17). The result of this study is in a way different than those of a previous study, which aimed to assess hypersensitivity relief of 2 different sealing techniques (resin-based sealant &#x00026; GIC-based sealant) in different times point. It showed a drastic decrease of the mean SCASS from 2.3 (&#x000b1;&#x02009;2.17) at baseline to 0.4 (&#x000b1;&#x02009;0.7) immediately after the treatment and to 0.1 (&#x000b1;&#x02009;0.41) after a time span of 12 week. Whereas, the results from a randomised control trial (RCT aimed to assess hypersensitivity reduction of silver-modified atraumatic restorative technique SMART (SDF&#x02009;+&#x02009;GIC), which showed a significant reduction from 1.77 (&#x000b1;&#x02009;0.83) to 0.08 (&#x000b1;&#x02009;0.28) for SMART, in which SMART showed a slightly more reduction in MIH hypersensitivity than SDF (Balikaya et al. <xref ref-type="bibr" rid="CR7">2022</xref>). This difference in the end-point SCASS score may be explained by the fact that the baseline SCASS in this study was initially higher than those of the two mentioned studies. Moreso MIH molars with persistent hypersensitivity referring to teeth which were in a way unreceptive to received previous desensitising treatments were also included (n&#x02009;=&#x02009;13) (Bekes et al. <xref ref-type="bibr" rid="CR10">2022</xref>).</p><p id="Par46">A recent study showed an improved oral health-related quality of life (OHRQol) in children with hypersensitive MIH molars after receiving an application of sealant coverage (Bekes et al. <xref ref-type="bibr" rid="CR9">2021</xref>). Thus a sealant coverage might be a helpful and simple tool to improve OHRQoL, due to the fact that a higher severity of MIH-TNI correlated significantly with impaired OHRQoL (Sekundo et al. <xref ref-type="bibr" rid="CR36">2024</xref>).</p><p id="Par47">In this study, hypersensitive MIH molars of a baseline SCASS score of 2 &#x00026; 3 reported a statistically significant reduction of hypersensitivity immediately and in 12 weeks period (P&#x02009;&#x0003c;&#x02009;<italic>0.05</italic>, Mann&#x02013;Whitney U test). Though still some of the hypersensitive MIH molars with baseline 2 (<italic>n</italic>&#x02009;=&#x02009;2, 10.5%) and SCASS 3 (<italic>n</italic>&#x02009;=&#x02009;13, 54%) reported a persistent hypersensitivity (SCASS&#x02009;&#x02265;&#x02009;2) as shown in Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref>. Based on a recent systematic review, due to difficulty in assessing subjective pain intensity, which is affected by the inherently subjective and intricate nature of pain, the clinical management of hypersensitivity is mainly defined as a contemporary approach through utilising a combination of in-office application adjacent with home-based desensitising agents such as toothpaste containing potassium salt, fluoride and hydroxyapatite (Dionysopoulos et al. <xref ref-type="bibr" rid="CR18">2023</xref>).</p><p id="Par48">However, the effect is more prominent after a 12 weeks period, in which hypersensitive MIH molars with a baseline SCASS of 2 showed a statistically higher reduction in the mean SCASS than those of baseline SCASS 3 (<italic>P</italic>&#x02009;=&#x02009;0.03, <italic>t</italic> test<bold><italic>;</italic></bold> Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref>). This difference can be explained by the fact that all hypersensitive MIH molars with baseline SCASS of 2 included in the study showed no post-treatment hypersensitivity (SCASS&#x02009;&#x0003c;&#x02009;2) while some of the MIH molars with high intensity of hypersensitivity (SCASS 3; <italic>n</italic>&#x02009;=&#x02009;8, 34.8%) reported a persistent hypersensitivity (Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref>). Based on previous studies, in almost all the patients, who received desensitisation treatments independent of the material used, an improvement in the SCASS values was observed., This emphasizes the hypothesis of starting from very high sensitivity values and a decrease over time. Repeating or combining desensitisors and enhancing sensory changes will stabilise the situation with time (Murri Dello Diago et al. <xref ref-type="bibr" rid="CR31">2021</xref>).</p><p id="Par49">In addition, the study analysis involved assessing the effect of GIC sealant application (Ionostar Plus&#x02009;+&#x02009;Easy Glaze, VOCO) on hypersensitivity reduction of MIH molars with (<italic>n</italic>&#x02009;=&#x02009;13, 30%) and without a history of desensitizing treatment (<italic>n</italic>&#x02009;=&#x02009;30, 70%) as shown in Table&#x000a0;<xref rid="Tab6" ref-type="table">6</xref>. Furthermore, this study included hypersensitive MIH molars with at least no history of desensitizing treatment prior to 1 month before the GIC sealant application. Previous studies investigating various treatment modalities on MIH hypersensitivity showed a significant end-point desensitizing effect within 4 weeks (Bekes et al <xref ref-type="bibr" rid="CR10">2022</xref>, <xref ref-type="bibr" rid="CR12">2017</xref>). Nevertheless, the study results didn&#x02019;t show any statistically significant difference in hypersensitivity reduction in MIH molars with and without prior desensitizing treatment (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). Whereas, hypersensitive MIH molars with no history of pre-treatment showed a higher rate of post-GIC-sealant hypersensitivity (SCASS&#x02009;&#x02265;&#x02009;2; <italic>n</italic>&#x02009;=&#x02009;9, 40.9%) than those without a history of pre-treatments (SCASS&#x02009;&#x02265;&#x02009;2; <italic>n</italic>&#x02009;=&#x02009;3, 23.1%) after 12 weeks post GIC sealant application (Table&#x000a0;<xref rid="Tab6" ref-type="table">6</xref>). Interestingly in this study, the pre-treatment group showed a statistically significant reduction in desensitization in the time frame of 15min &#x02013; 12 weeks (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). This supports the fact that the frequency of desensitisation treatment on MIH molars is also important for the longevity of the desensitising effect and that this technique is effective irrespective of the type of pre-treatment (Balikkaya et al., <xref ref-type="bibr" rid="CR7">2022</xref>).</p><p id="Par50">One secondary aim of the study involved the evaluation of the retention rate of GIC (Ionostar Plus&#x02009;+&#x02009;Easy Glaze, VOCO) on hypersensitive MIH molars over a period of 12 weeks. Based on the study results, fourteen GIC sealants (33.5%) were completely lost over a period of 12 weeks. In two of these cases there were even the presence of dentine caries (4.8%, Table&#x000a0;<xref rid="Tab7" ref-type="table">7</xref>). This retention rate is slightly lower than those of a similar study, which observed partial loss of the GIC sealant in 8 teeth (21.1%) but no caries presence over a period of 12 weeks (Bekes et al. <xref ref-type="bibr" rid="CR10">2022</xref>). This lower performance rate of the GIC sealant in this study might be explained by the fact that the study involved MIH molars with enamel breakdown to some extent more than the surface coverage of a conventional GIC sealant, which could be still used as an initial quick treatment until definitive restoration is placed (Fragelli et al., 2015). However, both studies showed comparable domains of deteriorations, which were marginal integrity and tactile surface texture (Bekes et al. <xref ref-type="bibr" rid="CR10">2022</xref>).</p><p id="Par51">According to a retrospective analysis of the retention of resin-based sealant on MIH molars, the retreatment rate was higher within 2 years and the failure risk was three times more than molars without MIH (Kotsanos et al. <xref ref-type="bibr" rid="CR24">2005</xref>). Based on the findings of 4-years follow-up study, a significant enhancement in the retention of fissure sealants in hypomineralised molars was observed when a single bottle adhesive system was applied prior to the placement of the resin-based sealant (Lygidakis et al. <xref ref-type="bibr" rid="CR29">2009</xref>). Whereas according to another clinical study, loss of the retention of resin-based sealant in MIH molars was observed in three teeth out of 25 teeth within four weeks (Fragelli et al., 2017), this is lower than those of the present study, in which three out of 42 GIC sealant were lost after 12 weeks.</p><p id="Par52">The fact that hypomineralised enamel has a higher porosity, reduced degree of hardness and elasticity with a change in carbon-carbonate ratios when compared to sound enamel (Elhennawy et al., 2017). This results in compromised bonding due to poor adhesion and reduced bonding strength in MIH-affected enamel (Lagarde et al. <xref ref-type="bibr" rid="CR25">2020</xref>). Thus the application of GIC sealant might be superior to resin-based sealants, which require optimal conditions such as excellent moisture control (Cvikl et al. <xref ref-type="bibr" rid="CR16">2018</xref>). On the contrary, glass ionomer cement sealants can serve as a suitable temporary treatment option in challenging clinical conditions where isolation is insufficient. This is due to their lower technique sensitive and their ability to set quickly without the need for intermediate steps like etching. This is particularly advantageous in cases where a sealing is necessary for a not fully erupted MIH molar, as well as for non-cooperative, anxious children or patients experiencing hypersensitivity and pain in their molars. The straightforward application procedure of glass ionomer cement sealants makes them a more convenient choice for children. Additionally, these sealants may offer the added benefit of fluoride release, making them a viable option for tooth preservation and caries protection (Elhennawy &#x00026; Schwendicke <xref ref-type="bibr" rid="CR20">2016</xref>). It has been proposed that the use of a GIC sealant can provide protection for molars affected by MIH against post-eruption enamel breakdown (Lygidakis <xref ref-type="bibr" rid="CR28">2010</xref>). The prevailing theory suggests that the fluoride found in this material may permeate into the affected enamel and dentin, promoting mineralization of the hypomineralized areas (Lygidakis <xref ref-type="bibr" rid="CR28">2010</xref>).</p><p id="Par53">The present study has some limitations, which included a higher sample size that would have been required for some secondary outcome variables, like the assessment of the retention rate of GIC sealant. A longer follow-up time frame would have been good to evaluate the domains of the deterioration and hypersensitivity relief over a longer period. In addition, the lack of untreated control, which would have been interesting for the interpretation of the study results. However, due to the high degree of hypersensitivity intensity, the lack of control (no in-office treatment) might have been not only unethical but also not feasible as parents would have refused in study participation. A comparative control group involving other standard desensitisation treatments, such as resin-based sealants, CPP-ACP pastes, sodium fluoride (NaF) varnish would have added more value to the results. Further investigations are required to assess hypersensitivity relief of combining GIC sealant with other standard desensitisation treatments such as CPP-ACP pastes, and sodium fluoride (NaF) varnish.</p></sec><sec id="Sec10"><title>Conclusion</title><p id="Par54">GIC coverage is highly effective in providing instant relief from hypersensitivity in MIH molars in schoolchildren and the effect even continues over a period of 12 weeks minimum. Furthermore, GIC sealant not only provides a significant reduction in hypersensitivity of freshly erupted MIH molars but also in cases of persistent hypersensitivity.</p></sec><sec id="Sec11" sec-type="supplementary-material"><title>Supplementary Information</title><p>Below is the link to the electronic supplementary material.<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="40368_2024_988_MOESM1_ESM.docx"><caption><p>Supplementary file1 (DOCX 33 KB)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="40368_2024_988_MOESM2_ESM.pdf"><caption><p>Supplementary file2 (PDF 877 KB)</p></caption></media></supplementary-material></p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We gratefully acknowledge the whole team of paediatric dentistry department at the University of Greifswald for their support. Moreso we thank VOCO (Germany) and Dr. Robert Schwiete Stiftung for the partial financial support of this project. A special thanks to Dr. Silvia Jarchow and Dr. Robert Schwiete Stiftung for their interest in the study and providing the required support and study materials. And finally, we thank all postgraduate dental students in the paediatric dentistry department for their support during the patient collection phase. This prospective clinical study was approved by the Local Ethics Committee (BB 047/23) and was conducted in strict adherence to the STROBE statement. The study protocol was registered on ClinicalTrials.gov (NCT05945381). All parents/caregivers were asked to sign an informed consent after thorough explanation of the procedures and possible outcomes of treatment. Children were excluded from the study when their parents declined to sign the form.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>R. Karim, C.H. Splieth and J. Schmoeckel conceived the ideas and designed the study; R. Karim, M.&#x000a0;Baider collected and analyzed the data with guidance from C.&#x000a0;H. Splieth, J. Schmoeckel; and R. Karim and J. Schmoeckel led the writing and drafted the manuscript with guidance from C.H. Splieth. All authors critically appraised, revised, and read and approved the manuscript. J. Schmoeckel, M.&#x000a0;Baider, and C.H. Splieth conducted the final analysis, contributed to the final version of the manuscript, and approved the final manuscript as submitted. All authors critically appraised, revised, and read and approved the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding enabled and organized by Projekt DEAL. This study was partially funded by the company VOCOGmbH&#x000a0;&#x00026; received a research grant by Dr. Rolf M. Schwiete Stiftung by an agreement with the University Medicine&#x000a0;of Greifswald.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The dataset used in this study contains sensitive details of paediatric patients, which can&#x02019;t be uploaded to an open repository for ethical reasons.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par55">The first author received for his postgraduate PhD project a partial financial support from VOCO GmbH, Germany. All authors declare no potential conflicts of interest with respect to authorship and/or publication of this article.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><mixed-citation publication-type="other">Ahovuo&#x02010;Saloranta, A., Forss, H., Walsh, T., Nordblad, A., M&#x000e4;kel&#x000e4;, M., &#x00026; Worthington, H. V. (2017). Pit and fissure sealants for preventing dental decay in permanent teeth.&#x000a0;<italic>Cochrane database of systematic reviews</italic>, (7).</mixed-citation></ref><ref id="CR2"><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Nerabieah</surname><given-names>Z</given-names></name><name><surname>AlKhouli</surname><given-names>M</given-names></name><name><surname>Dashash</surname><given-names>M</given-names></name></person-group><article-title>Parental satisfaction and acceptance of silver diamine fluoride treatment for molar incisor hypomineralisation in pediatric dentistry: a cross-sectional study</article-title><source>Sci Rep</source><year>2024</year><volume>14</volume><issue>1</issue><fpage>4544</fpage><pub-id pub-id-type="pmid">38402306</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Al-Nerabieah Z, AlKhouli M, Dashash M. Parental satisfaction and acceptance of silver diamine fluoride treatment for molar incisor hypomineralisation in pediatric dentistry: a cross-sectional study. Sci Rep. 2024;14(1):4544.<pub-id pub-id-type="pmid">38402306</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><mixed-citation publication-type="other">American Academy of Pediatric Dentistry. Caries-risk assessment and management for infants, children, and adolescents. The Reference Manual of Pediatric Dentistry. Chicago, Ill.: American Academy of Pediatric Dentistry; 2023:301&#x02013;7.</mixed-citation></ref><ref id="CR4"><mixed-citation publication-type="other">Americano, Gabriela CA, and Vera M. Soviero. (2020). Association between molar incisor hypomineralization and dental caries.&#x000a0;molar incisor hypomineralization: a clinical guide to diagnosis and treatment: 59&#x02013;69.</mixed-citation></ref><ref id="CR5"><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Awwad</surname><given-names>A</given-names></name><name><surname>Hamad</surname><given-names>R</given-names></name><name><surname>Schiffner</surname><given-names>U</given-names></name><name><surname>Splieth</surname><given-names>CH</given-names></name><name><surname>Schmoeckel</surname><given-names>J</given-names></name></person-group><article-title>Effect of prevalence and severity of molar-incisor hypomineralization on oral health-related quality of life: a systematic review and meta-analysis</article-title><source>Acta Stomatologica Croatica Intern J Oral Sci Dental Med</source><year>2023</year><volume>57</volume><issue>4</issue><fpage>381</fpage><lpage>394</lpage></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Awwad A, Hamad R, Schiffner U, Splieth CH, Schmoeckel J. Effect of prevalence and severity of molar-incisor hypomineralization on oral health-related quality of life: a systematic review and meta-analysis. Acta Stomatologica Croatica Intern J Oral Sci Dental Med. 2023;57(4):381&#x02013;94.</mixed-citation></citation-alternatives></ref><ref id="CR6"><mixed-citation publication-type="other">Bakkal, M., Abbasoglu, Z., &#x00026; Kargul, B. (2017). The Effect of Casein Phosphopeptide-amorphous calcium phosphate on molar-incisor hypomineralisation: a pilot study.&#x000a0;oral health &#x00026; preventive dentistry,&#x000a0;15(2).</mixed-citation></ref><ref id="CR7"><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Ballikaya</surname><given-names>E</given-names></name><name><surname>&#x000dc;nverdi</surname><given-names>GE</given-names></name><name><surname>Cehreli</surname><given-names>ZC</given-names></name></person-group><article-title>Management of initial carious lesions of hypomineralized molars (MIH) with silver diamine fluoride or silver-modified atraumatic restorative treatment (SMART): 1-year results of a prospective, randomized clinical trial</article-title><source>Clin Oral Invest</source><year>2022</year></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Ballikaya E, &#x000dc;nverdi GE, Cehreli ZC. Management of initial carious lesions of hypomineralized molars (MIH) with silver diamine fluoride or silver-modified atraumatic restorative treatment (SMART): 1-year results of a prospective, randomized clinical trial. Clin Oral Invest. 2022. 10.1007/s00784-021-04236-5.</mixed-citation></citation-alternatives></ref><ref id="CR8"><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Baroni</surname><given-names>C</given-names></name><name><surname>Marchionni</surname><given-names>S</given-names></name></person-group><article-title>MIH supplementation strategies: prospective clinical and laboratory trial</article-title><source>J Dent Res</source><year>2011</year><volume>90</volume><issue>3</issue><fpage>371</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">21149856</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Baroni C, Marchionni S. MIH supplementation strategies: prospective clinical and laboratory trial. J Dent Res. 2011;90(3):371&#x02013;6.<pub-id pub-id-type="pmid">21149856</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Bekes</surname><given-names>K</given-names></name><name><surname>Amend</surname><given-names>S</given-names></name><name><surname>Priller</surname><given-names>J</given-names></name><name><surname>Zamek</surname><given-names>C</given-names></name><name><surname>Stamm</surname><given-names>T</given-names></name><name><surname>Kr&#x000e4;mer</surname><given-names>N</given-names></name></person-group><article-title>Changes in oral health-related quality of life after treatment of hypersensitive molar incisor hypomineralization&#x02013;affected molars with a sealing</article-title><source>Clin Oral Invest</source><year>2021</year><volume>25</volume><fpage>6449</fpage><lpage>6454</lpage></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Bekes K, Amend S, Priller J, Zamek C, Stamm T, Kr&#x000e4;mer N. Changes in oral health-related quality of life after treatment of hypersensitive molar incisor hypomineralization&#x02013;affected molars with a sealing. Clin Oral Invest. 2021;25:6449&#x02013;54.</mixed-citation></citation-alternatives></ref><ref id="CR10"><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Bekes</surname><given-names>K</given-names></name><name><surname>Amend</surname><given-names>S</given-names></name><name><surname>Priller</surname><given-names>J</given-names></name><name><surname>Zamek</surname><given-names>C</given-names></name><name><surname>Stamm</surname><given-names>T</given-names></name><name><surname>Kr&#x000e4;mer</surname><given-names>N</given-names></name></person-group><article-title>Hypersensitivity relief of MIH-affected molars using two sealing techniques: a 12-week follow-up</article-title><source>Clin Oral Invest</source><year>2022</year><volume>26</volume><issue>2</issue><fpage>1879</fpage><lpage>1888</lpage></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Bekes K, Amend S, Priller J, Zamek C, Stamm T, Kr&#x000e4;mer N. Hypersensitivity relief of MIH-affected molars using two sealing techniques: a 12-week follow-up. Clin Oral Invest. 2022;26(2):1879&#x02013;88.</mixed-citation></citation-alternatives></ref><ref id="CR11"><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Bekes</surname><given-names>K</given-names></name><name><surname>Steffen</surname><given-names>R</given-names></name><name><surname>Kr&#x000e4;mer</surname><given-names>N</given-names></name></person-group><article-title>Update of the molar incisor hypomineralization: W&#x000fc;rzburg concept</article-title><source>Eur Arch Paediatr Dent</source><year>2023</year><volume>24</volume><issue>6</issue><fpage>807</fpage><lpage>813</lpage><pub-id pub-id-type="pmid">37856065</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Bekes K, Steffen R, Kr&#x000e4;mer N. Update of the molar incisor hypomineralization: W&#x000fc;rzburg concept. Eur Arch Paediatr Dent. 2023;24(6):807&#x02013;13.<pub-id pub-id-type="pmid">37856065</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Bekes</surname><given-names>K</given-names></name><name><surname>Heinzelmann</surname><given-names>K</given-names></name><name><surname>Lettner</surname><given-names>S</given-names></name><name><surname>Schaller</surname><given-names>HG</given-names></name></person-group><article-title>Efficacy of desensitizing products containing 8% arginine and calcium carbonate for hypersensitivity relief in MIH-afected molars: an 8-week clinical study</article-title><source>Clin Oral Investig</source><year>2017</year><pub-id pub-id-type="pmid">28210811</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Bekes K, Heinzelmann K, Lettner S, Schaller HG. Efficacy of desensitizing products containing 8% arginine and calcium carbonate for hypersensitivity relief in MIH-afected molars: an 8-week clinical study. Clin Oral Investig. 2017. 10.1007/s00784-016-2024-8.<pub-id pub-id-type="pmid">28210811</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Bijur</surname><given-names>PE</given-names></name><name><surname>Silver</surname><given-names>W</given-names></name><name><surname>Gallagher</surname><given-names>EJ</given-names></name></person-group><article-title>Reliability of the visual analog scale for measurement of acute pain</article-title><source>Acad Emerg Med</source><year>2001</year><volume>8</volume><issue>12</issue><fpage>1153</fpage><lpage>1157</lpage><pub-id pub-id-type="pmid">11733293</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Bijur PE, Silver W, Gallagher EJ. Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med. 2001;8(12):1153&#x02013;7.<pub-id pub-id-type="pmid">11733293</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Biondi</surname><given-names>AM</given-names></name><name><surname>Cortese</surname><given-names>SG</given-names></name><name><surname>Babino</surname><given-names>L</given-names></name><name><surname>Fridman</surname><given-names>DE</given-names></name></person-group><article-title>Comparison of Mineral Density in Molar Incisor Hypomineralization applying fluoride varnishes and casein phosphopeptide-amorphous calcium phosphate</article-title><source>Acta Odontol Latinoam</source><year>2017</year><volume>30</volume><issue>3</issue><fpage>118</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">29750235</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Biondi AM, Cortese SG, Babino L, Fridman DE. Comparison of Mineral Density in Molar Incisor Hypomineralization applying fluoride varnishes and casein phosphopeptide-amorphous calcium phosphate. Acta Odontol Latinoam. 2017;30(3):118&#x02013;23.<pub-id pub-id-type="pmid">29750235</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Butera</surname><given-names>A</given-names></name><name><surname>Pascadopoli</surname><given-names>M</given-names></name><name><surname>Pellegrini</surname><given-names>M</given-names></name><name><surname>Trapani</surname><given-names>B</given-names></name><name><surname>Gallo</surname><given-names>S</given-names></name><name><surname>Radu</surname><given-names>M</given-names></name><name><surname>Scribante</surname><given-names>A</given-names></name></person-group><article-title>Biomimetic hydroxyapatite paste for molar&#x02013;incisor hypomineralization: a randomized clinical trial</article-title><source>Oral Dis</source><year>2023</year><volume>29</volume><issue>7</issue><fpage>2789</fpage><lpage>2798</lpage><pub-id pub-id-type="pmid">36135352</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Butera A, Pascadopoli M, Pellegrini M, Trapani B, Gallo S, Radu M, Scribante A. Biomimetic hydroxyapatite paste for molar&#x02013;incisor hypomineralization: a randomized clinical trial. Oral Dis. 2023;29(7):2789&#x02013;98.<pub-id pub-id-type="pmid">36135352</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Cvikl</surname><given-names>B</given-names></name><name><surname>Moritz</surname><given-names>A</given-names></name><name><surname>Bekes</surname><given-names>K</given-names></name></person-group><article-title>Pit and fissure sealants&#x02014;a comprehensive review</article-title><source>Dent J</source><year>2018</year><volume>6</volume><issue>2</issue><fpage>18</fpage></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Cvikl B, Moritz A, Bekes K. Pit and fissure sealants&#x02014;a comprehensive review. Dent J. 2018;6(2):18.</mixed-citation></citation-alternatives></ref><ref id="CR17"><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>De Farias</surname><given-names>AL</given-names></name><name><surname>Rojas-Gualdr&#x000f3;n</surname><given-names>DF</given-names></name><name><surname>Girotto Bussaneli</surname><given-names>D</given-names></name><name><surname>Santos-Pinto</surname><given-names>L</given-names></name><name><surname>Mej&#x000ed;a</surname><given-names>JD</given-names></name><name><surname>Restrepo</surname><given-names>M</given-names></name></person-group><article-title>Does molar-incisor hypomineralization (MIH) affect only permanent first molars and incisors? New observations on permanent second molars</article-title><source>Int J Pediatr Dent</source><year>2022</year><volume>32</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage></element-citation><mixed-citation id="mc-CR17" publication-type="journal">De Farias AL, Rojas-Gualdr&#x000f3;n DF, Girotto Bussaneli D, Santos-Pinto L, Mej&#x000ed;a JD, Restrepo M. Does molar-incisor hypomineralization (MIH) affect only permanent first molars and incisors? New observations on permanent second molars. Int J Pediatr Dent. 2022;32(1):1&#x02013;10.</mixed-citation></citation-alternatives></ref><ref id="CR18"><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Dionysopoulos</surname><given-names>D</given-names></name><name><surname>Gerasimidou</surname><given-names>O</given-names></name><name><surname>Beltes</surname><given-names>C</given-names></name></person-group><article-title>Dentin hypersensitivity: etiology, diagnosis and contemporary therapeutic approaches&#x02014;a review in literature</article-title><source>Appl Sci</source><year>2023</year><volume>13</volume><issue>21</issue><fpage>11632</fpage></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Dionysopoulos D, Gerasimidou O, Beltes C. Dentin hypersensitivity: etiology, diagnosis and contemporary therapeutic approaches&#x02014;a review in literature. Appl Sci. 2023;13(21):11632.</mixed-citation></citation-alternatives></ref><ref id="CR19"><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Ehlers</surname><given-names>V</given-names></name><name><surname>Reuter</surname><given-names>AK</given-names></name><name><surname>Kehl</surname><given-names>EB</given-names></name><name><surname>Enax</surname><given-names>J</given-names></name><name><surname>Meyer</surname><given-names>F</given-names></name><name><surname>Schlecht</surname><given-names>J</given-names></name><name><surname>Schmidtmann</surname><given-names>I</given-names></name><name><surname>Deschner</surname><given-names>J</given-names></name></person-group><article-title>Efficacy of a toothpaste based on microcrystalline hydroxyapatite on children with hypersensitivity caused by MIH: A randomised controlled trial</article-title><source>Oral Health Prev Dent</source><year>2021</year><volume>19</volume><issue>1</issue><fpage>647</fpage><lpage>658</lpage><pub-id pub-id-type="pmid">34874142</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Ehlers V, Reuter AK, Kehl EB, Enax J, Meyer F, Schlecht J, Schmidtmann I, Deschner J. Efficacy of a toothpaste based on microcrystalline hydroxyapatite on children with hypersensitivity caused by MIH: A randomised controlled trial. Oral Health Prev Dent. 2021;19(1):647&#x02013;58.<pub-id pub-id-type="pmid">34874142</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Elhennawy</surname><given-names>K</given-names></name><name><surname>Schwendicke</surname><given-names>F</given-names></name></person-group><article-title>Managing molar-incisor hypomineralization: A systematic review</article-title><source>J Dent</source><year>2016</year><volume>55</volume><fpage>16</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">27693779</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Elhennawy K, Schwendicke F. Managing molar-incisor hypomineralization: A systematic review. J Dent. 2016;55:16&#x02013;24.<pub-id pub-id-type="pmid">27693779</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Fagrell</surname><given-names>TG</given-names></name><name><surname>Dietz</surname><given-names>W</given-names></name><name><surname>J&#x000e4;levik</surname><given-names>B</given-names></name><name><surname>Nor&#x000e9;n</surname><given-names>JG</given-names></name></person-group><article-title>Chemical, mechanical and morphological properties of hypomineralized enamel of permanent first molars</article-title><source>Acta Odontol Scand</source><year>2010</year><volume>68</volume><issue>4</issue><fpage>215</fpage><lpage>222</lpage><pub-id pub-id-type="pmid">20392131</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Fagrell TG, Dietz W, J&#x000e4;levik B, Nor&#x000e9;n JG. Chemical, mechanical and morphological properties of hypomineralized enamel of permanent first molars. Acta Odontol Scand. 2010;68(4):215&#x02013;22.<pub-id pub-id-type="pmid">20392131</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>J&#x000e4;levik</surname><given-names>B</given-names></name><name><surname>Klingberg</surname><given-names>GA</given-names></name></person-group><article-title>Dental treatment, dental fear and behaviour management problems in children with severe enamel hypomineralization of their permanent first molars</article-title><source>Int J Pediatr Dent</source><year>2002</year><volume>12</volume><issue>1</issue><fpage>24</fpage><lpage>32</lpage></element-citation><mixed-citation id="mc-CR22" publication-type="journal">J&#x000e4;levik B, Klingberg GA. Dental treatment, dental fear and behaviour management problems in children with severe enamel hypomineralization of their permanent first molars. Int J Pediatr Dent. 2002;12(1):24&#x02013;32.</mixed-citation></citation-alternatives></ref><ref id="CR23"><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Keck</surname><given-names>JF</given-names></name><name><surname>Gerkensmeyer</surname><given-names>JE</given-names></name><name><surname>Joyce</surname><given-names>BA</given-names></name><name><surname>Schade</surname><given-names>JG</given-names></name></person-group><article-title>Reliability and validity of the faces and word descriptor scales to measure procedural pain</article-title><source>J Pediatr Nurs</source><year>1996</year><volume>11</volume><issue>6</issue><fpage>368</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">8991337</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Keck JF, Gerkensmeyer JE, Joyce BA, Schade JG. Reliability and validity of the faces and word descriptor scales to measure procedural pain. J Pediatr Nurs. 1996;11(6):368&#x02013;74.<pub-id pub-id-type="pmid">8991337</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Kotsanos</surname><given-names>N</given-names></name><name><surname>Kaklamanos</surname><given-names>EG</given-names></name><name><surname>Arapostathis</surname><given-names>K</given-names></name></person-group><article-title>Treatment management of first permanent molars in children with Molar-Incisor Hypomineralisation</article-title><source>Eur J Paediatr Dent</source><year>2005</year><volume>6</volume><issue>4</issue><fpage>179</fpage><pub-id pub-id-type="pmid">16426116</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Kotsanos N, Kaklamanos EG, Arapostathis K. Treatment management of first permanent molars in children with Molar-Incisor Hypomineralisation. Eur J Paediatr Dent. 2005;6(4):179.<pub-id pub-id-type="pmid">16426116</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Lagarde</surname><given-names>M</given-names></name><name><surname>Vennat</surname><given-names>E</given-names></name><name><surname>Attal</surname><given-names>JP</given-names></name><name><surname>Dursun</surname><given-names>E</given-names></name></person-group><article-title>Strategies to optimize bonding of adhesive materials to molar-incisor hypomineralization-affected enamel: A systematic review</article-title><source>Int J Pediatr Dent</source><year>2020</year><volume>30</volume><issue>4</issue><fpage>405</fpage><lpage>420</lpage></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Lagarde M, Vennat E, Attal JP, Dursun E. Strategies to optimize bonding of adhesive materials to molar-incisor hypomineralization-affected enamel: A systematic review. Int J Pediatr Dent. 2020;30(4):405&#x02013;20.</mixed-citation></citation-alternatives></ref><ref id="CR26"><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Linner</surname><given-names>T</given-names></name><name><surname>Khazaei</surname><given-names>Y</given-names></name><name><surname>B&#x000fc;cher</surname><given-names>K</given-names></name><name><surname>Pfisterer</surname><given-names>J</given-names></name><name><surname>Hickel</surname><given-names>R</given-names></name><name><surname>K&#x000fc;hnisch</surname><given-names>J</given-names></name></person-group><article-title>Hypersensitivity in teeth affected by molar-incisor hypomineralization (MIH)</article-title><source>Sci Rep</source><year>2021</year><volume>11</volume><issue>1</issue><fpage>17922</fpage><pub-id pub-id-type="pmid">34504122</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Linner T, Khazaei Y, B&#x000fc;cher K, Pfisterer J, Hickel R, K&#x000fc;hnisch J. Hypersensitivity in teeth affected by molar-incisor hypomineralization (MIH). Sci Rep. 2021;11(1):17922.<pub-id pub-id-type="pmid">34504122</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Llodra</surname><given-names>JC</given-names></name><name><surname>Bravo</surname><given-names>M</given-names></name><name><surname>Delgado-Rodriguez</surname><given-names>M</given-names></name><name><surname>Baca</surname><given-names>P</given-names></name><name><surname>Galvez</surname><given-names>R</given-names></name></person-group><article-title>Factors influencing the effectiveness of sealants&#x02013;a meta-analysis</article-title><source>Commun Dent Oral Epidemiol</source><year>1993</year><volume>21</volume><issue>5</issue><fpage>261</fpage><lpage>268</lpage></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Llodra JC, Bravo M, Delgado-Rodriguez M, Baca P, Galvez R. Factors influencing the effectiveness of sealants&#x02013;a meta-analysis. Commun Dent Oral Epidemiol. 1993;21(5):261&#x02013;8.</mixed-citation></citation-alternatives></ref><ref id="CR28"><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Lygidakis</surname><given-names>NA</given-names></name></person-group><article-title>Treatment modalities in children with teeth affected by molar-incisor enamel hypomineralisation (MIH): a systematic review</article-title><source>Eur Arch Paediatr Dent</source><year>2010</year><volume>11</volume><fpage>65</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">20403300</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Lygidakis NA. Treatment modalities in children with teeth affected by molar-incisor enamel hypomineralisation (MIH): a systematic review. Eur Arch Paediatr Dent. 2010;11:65&#x02013;74.<pub-id pub-id-type="pmid">20403300</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Lygidakis</surname><given-names>NA</given-names></name><name><surname>Dimou</surname><given-names>G</given-names></name><name><surname>Stamataki</surname><given-names>E</given-names></name></person-group><article-title>Retention of fissure sealants using two different methods of application in teeth with hypomineralised molars (MIH): a 4 year clinical study</article-title><source>Eur Arch Paediatr Dent</source><year>2009</year><volume>10</volume><issue>4</issue><fpage>223</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">19995506</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Lygidakis NA, Dimou G, Stamataki E. Retention of fissure sealants using two different methods of application in teeth with hypomineralised molars (MIH): a 4 year clinical study. Eur Arch Paediatr Dent. 2009;10(4):223&#x02013;6.<pub-id pub-id-type="pmid">19995506</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Lygidakis</surname><given-names>NA</given-names></name><name><surname>Garot</surname><given-names>E</given-names></name><name><surname>Somani</surname><given-names>C</given-names></name><name><surname>Taylor</surname><given-names>GD</given-names></name><name><surname>Rouas</surname><given-names>P</given-names></name><name><surname>Wong</surname><given-names>FSL</given-names></name></person-group><article-title>Best clinical practice guidance for clinicians dealing with children presenting with molar-incisor-hypomineralisation (MIH): an updated European Academy of Paediatric Dentistry policy document</article-title><source>Eur Arch Paediatr Dent</source><year>2022</year><pub-id pub-id-type="pmid">36219336</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Lygidakis NA, Garot E, Somani C, Taylor GD, Rouas P, Wong FSL. Best clinical practice guidance for clinicians dealing with children presenting with molar-incisor-hypomineralisation (MIH): an updated European Academy of Paediatric Dentistry policy document. Eur Arch Paediatr Dent. 2022. 10.1007/s40368-021-00668-5.<pub-id pub-id-type="pmid">36219336</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Murri Dello Diago</surname><given-names>A</given-names></name><name><surname>Cadenaro</surname><given-names>M</given-names></name><name><surname>Ricchiuto</surname><given-names>R</given-names></name><name><surname>Banchelli</surname><given-names>F</given-names></name><name><surname>Spinas</surname><given-names>E</given-names></name><name><surname>Checchi</surname><given-names>V</given-names></name><name><surname>Giannetti</surname><given-names>L</given-names></name></person-group><article-title>Hypersensitivity in molar incisor hypomineralization: Superficial infiltration treatment</article-title><source>Appl Sci</source><year>2021</year><volume>11</volume><issue>4</issue><fpage>1823</fpage></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Murri Dello Diago A, Cadenaro M, Ricchiuto R, Banchelli F, Spinas E, Checchi V, Giannetti L. Hypersensitivity in molar incisor hypomineralization: Superficial infiltration treatment. Appl Sci. 2021;11(4):1823.</mixed-citation></citation-alternatives></ref><ref id="CR32"><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Pasini</surname><given-names>M</given-names></name><name><surname>Giuca</surname><given-names>MR</given-names></name><name><surname>Scatena</surname><given-names>M</given-names></name><name><surname>Gatto</surname><given-names>R</given-names></name><name><surname>Caruso</surname><given-names>S</given-names></name></person-group><article-title>Molar incisor hypomineralization treatment with casein phosphopeptide and amorphous calcium phosphate in children</article-title><source>Minerva Stomatol</source><year>2017</year><volume>67</volume><issue>1</issue><fpage>20</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">28975773</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Pasini M, Giuca MR, Scatena M, Gatto R, Caruso S. Molar incisor hypomineralization treatment with casein phosphopeptide and amorphous calcium phosphate in children. Minerva Stomatol. 2017;67(1):20&#x02013;5.<pub-id pub-id-type="pmid">28975773</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Raposo</surname><given-names>F</given-names></name><name><surname>de Carvalho Rodrigues</surname><given-names>AC</given-names></name><name><surname>Lia</surname><given-names>&#x000c9;N</given-names></name><name><surname>Leal</surname><given-names>SC</given-names></name></person-group><article-title>Prevalence of hypersensitivity in teeth affected by molar-incisor hypomineralization (MIH)</article-title><source>Caries Res</source><year>2019</year><volume>53</volume><issue>4</issue><fpage>424</fpage><lpage>430</lpage><pub-id pub-id-type="pmid">30677762</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Raposo F, de Carvalho Rodrigues AC, Lia &#x000c9;N, Leal SC. Prevalence of hypersensitivity in teeth affected by molar-incisor hypomineralization (MIH). Caries Res. 2019;53(4):424&#x02013;30.<pub-id pub-id-type="pmid">30677762</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Restrepo</surname><given-names>M</given-names></name><name><surname>Jeremias</surname><given-names>F</given-names></name><name><surname>Santos-Pinto</surname><given-names>L</given-names></name><name><surname>Cordeiro</surname><given-names>RC</given-names></name><name><surname>Zuanon</surname><given-names>AC</given-names></name></person-group><article-title>Effect of fluoride varnish on enamel remineralization in anterior teeth with molar incisor hypomineralization</article-title><source>J Clin Pediatr Dent</source><year>2016</year><volume>40</volume><issue>3</issue><fpage>207</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">27472567</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Restrepo M, Jeremias F, Santos-Pinto L, Cordeiro RC, Zuanon AC. Effect of fluoride varnish on enamel remineralization in anterior teeth with molar incisor hypomineralization. J Clin Pediatr Dent. 2016;40(3):207&#x02013;10.<pub-id pub-id-type="pmid">27472567</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><mixed-citation publication-type="other">Schiff, T., Delgado, E. V. A. R. I. S. T. O., Zhang, Y. P., Cummins, D. I. A. N. E., DeVizio, W., &#x00026; Mateo, L. R. (2009). Clinical evaluation of the efficacy of an in-office desensitizing paste containing 8% arginine and calcium carbonate in providing instant and lasting relief of dentin hypersensitivity.American J Dent.&#x000a0;22(Special No A), 8A-15A.</mixed-citation></ref><ref id="CR36"><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Sekundo</surname><given-names>C</given-names></name><name><surname>Jung</surname><given-names>M</given-names></name><name><surname>Muscholl</surname><given-names>C</given-names></name><name><surname>Frese</surname><given-names>C</given-names></name></person-group><article-title>Oral health-related quality of life and survival analysis after preventive and restorative treatment of molar-incisor hypomineralisation</article-title><source>Sci Rep</source><year>2024</year><volume>14</volume><issue>1</issue><fpage>777</fpage><pub-id pub-id-type="pmid">38191504</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Sekundo C, Jung M, Muscholl C, Frese C. Oral health-related quality of life and survival analysis after preventive and restorative treatment of molar-incisor hypomineralisation. Sci Rep. 2024;14(1):777.<pub-id pub-id-type="pmid">38191504</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Solinas</surname><given-names>G</given-names></name><name><surname>Grabesu</surname><given-names>V</given-names></name><name><surname>Lattari</surname><given-names>M</given-names></name><name><surname>Strinna</surname><given-names>R</given-names></name><name><surname>Arnould</surname><given-names>N</given-names></name><name><surname>Amodeo</surname><given-names>AA</given-names></name></person-group><article-title>Management of a hypomineralisation of the enamel by applying a remineraliser based on zinc hydroxyapatite (microRepair)</article-title><source>Case Report Dent</source><year>2021</year><volume>2021</volume><issue>1</issue><fpage>5291858</fpage></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Solinas G, Grabesu V, Lattari M, Strinna R, Arnould N, Amodeo AA. Management of a hypomineralisation of the enamel by applying a remineraliser based on zinc hydroxyapatite (microRepair). Case Report Dent. 2021;2021(1):5291858.</mixed-citation></citation-alternatives></ref><ref id="CR38"><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Sterne</surname><given-names>JA</given-names></name><name><surname>Hern&#x000e1;n</surname><given-names>MA</given-names></name><name><surname>Reeves</surname><given-names>BC</given-names></name><name><surname>Savovi&#x00107;</surname><given-names>J</given-names></name><name><surname>Berkman</surname><given-names>ND</given-names></name><name><surname>Viswanathan</surname><given-names>M</given-names></name><name><surname>Henry</surname><given-names>D</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Ansari</surname><given-names>MT</given-names></name><name><surname>Boutron</surname><given-names>I</given-names></name><name><surname>Carpenter</surname><given-names>JR</given-names></name></person-group><article-title>ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions</article-title><source>BMJ</source><year>2016</year><pub-id pub-id-type="pmid">27737834</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Sterne JA, Hern&#x000e1;n MA, Reeves BC, Savovi&#x00107; J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016. 10.1136/bmj.i4919.<pub-id pub-id-type="pmid">27737834</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Vano</surname><given-names>M</given-names></name><name><surname>Derchi</surname><given-names>G</given-names></name><name><surname>Barone</surname><given-names>A</given-names></name><name><surname>Pinna</surname><given-names>R</given-names></name><name><surname>Usai</surname><given-names>P</given-names></name><name><surname>Covani</surname><given-names>U</given-names></name></person-group><article-title>Reducing dentine hypersensitivity with nano-hydroxyapatite toothpaste: a double-blind randomized controlled trial</article-title><source>Clin Oral Invest</source><year>2018</year><volume>22</volume><fpage>313</fpage><lpage>320</lpage></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Vano M, Derchi G, Barone A, Pinna R, Usai P, Covani U. Reducing dentine hypersensitivity with nano-hydroxyapatite toothpaste: a double-blind randomized controlled trial. Clin Oral Invest. 2018;22:313&#x02013;20.</mixed-citation></citation-alternatives></ref><ref id="CR40"><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Weerheijm</surname><given-names>KL</given-names></name></person-group><article-title>Molar incisor hypomineralisation (MIH)</article-title><source>Eur J Paediatr Dent</source><year>2003</year><volume>4</volume><fpage>114</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">14529330</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Weerheijm KL. Molar incisor hypomineralisation (MIH). Eur J Paediatr Dent. 2003;4:114&#x02013;20.<pub-id pub-id-type="pmid">14529330</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>DLBC</given-names></name></person-group><article-title>Pain in children: comparison of assessment scales</article-title><source>Pediatr Nurs</source><year>1988</year><volume>14</volume><issue>1</issue><fpage>9</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">3344163</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Wong DLBC. Pain in children: comparison of assessment scales. Pediatr Nurs. 1988;14(1):9&#x02013;17.<pub-id pub-id-type="pmid">3344163</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Dong</surname><given-names>B</given-names></name><name><surname>Yu</surname><given-names>D</given-names></name><name><surname>Ren</surname><given-names>Q</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name></person-group><article-title>The prevalence of molar incisor hypomineralization: evidence from 70 studies</article-title><source>Int J Pediatr Dent</source><year>2018</year><volume>28</volume><issue>2</issue><fpage>170</fpage><lpage>179</lpage></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Zhao D, Dong B, Yu D, Ren Q, Sun Y. The prevalence of molar incisor hypomineralization: evidence from 70 studies. Int J Pediatr Dent. 2018;28(2):170&#x02013;9.</mixed-citation></citation-alternatives></ref></ref-list></back></article>